canonical_name,synonyms,category,evidence_level,evidence_summary,dose_min,dose_max,dose_unit,dose_notes,perimenopause_specific,primary_claim,ssri_interaction,thyroid_interaction,bleeding_risk,liver_caution,hormone_active,pregnancy_safe,regulatory_risk,research_gaps
Magnesium Glycinate,Magnesium bisglycinate; as Magnesium Glycinate; Magnesium diglycinate; MgG,Mineral,Strong,"Multiple RCTs support magnesium supplementation for sleep quality, mood, and muscle function. Glycinate form shows superior tolerability and bioavailability versus oxide; specific perimenopause RCTs limited but sleep and anxiety benefits broadly demonstrated.",100,400,mg,Glycinate form has higher bioavailability than oxide; split doses improve absorption; upper tolerable limit 350mg supplemental per day (EU/UK); take with food to reduce GI effects.,Yes,Sleep support,No,Possible,No,No,No,Yes,Low,No large RCTs specifically in perimenopausal women measuring hot flush frequency or hormonal outcomes.
Magnesium Oxide,Mag oxide; MgO; as Magnesium Oxide,Mineral,Some,RCTs show modest benefit for constipation and migraine prevention. Bioavailability significantly lower than organic forms (~4%); limited evidence for mood or sleep at typical supplement doses.,200,500,mg,Poor bioavailability (~4%); primarily acts as osmotic laxative at higher doses; not recommended as preferred form for systemic magnesium repletion.,No,Laxative effect,No,Possible,No,No,No,Yes,Low,No head-to-head RCTs comparing forms specifically in perimenopausal populations.
Magnesium Citrate,Magnesium citrate anhydrous; as Magnesium Citrate,Mineral,Some,RCTs support use for constipation and kidney stone prevention. Intermediate bioavailability (~25%); commonly used in sleep and relaxation formulas though RCT evidence for these outcomes is thinner than for glycinate form.,150,400,mg,Better absorbed than oxide; commonly used in powder drink formats; may have mild laxative effect at doses above 400mg.,No,Constipation relief,No,Possible,No,No,No,Yes,Low,Limited direct comparison RCTs between citrate and glycinate for mood and sleep outcomes.
Magnesium Malate,Dimagnesium malate; as Magnesium Malate,Mineral,Limited,Small RCTs suggest benefit for fibromyalgia pain and fatigue. Malic acid component may support mitochondrial energy production. Limited perimenopause-specific evidence.,150,400,mg,May be particularly suited to energy and fatigue applications due to malic acid component; limited safety data at high doses long-term.,No,Fatigue reduction,No,Possible,No,No,No,Yes,Low,No RCTs in perimenopausal women; fibromyalgia evidence not directly translatable.
Magnesium Taurate,Magnesium ditaurate; as Magnesium Taurate,Mineral,Limited,Very limited human RCT data. Theoretical cardiovascular and neurological benefits from combined magnesium and taurine. Animal data more extensive than human trials.,125,500,mg,Taurine component may offer additional cardiovascular benefit; limited human RCT data limits dosing guidance.,No,Cardiovascular support,No,Possible,No,No,No,Yes,Low,Almost no human RCT data; clinical utility versus other forms unestablished.
Calcium Carbonate,As Calcium Carbonate; CaCO3; chalk,Mineral,Strong,Strong evidence for bone density maintenance when combined with vitamin D. Carbonate form requires stomach acid for absorption; less effective in older women with reduced gastric acid. Excess calcium supplementation associated with cardiovascular risk in some meta-analyses.,500,1200,mg,Must be taken with food to optimise absorption; split doses of 500mg improve uptake; total calcium intake (diet + supplement) should not exceed 2500mg/day.,Yes,Bone density,No,Yes,No,No,No,Yes,Low,Long-term cardiovascular safety of calcium supplementation in perimenopausal women remains debated.
Calcium Citrate,As Calcium Citrate; calcium citrate tetrahydrate,Mineral,Strong,Superior absorption to carbonate particularly in achlorhydria and post-menopausal women with reduced gastric acid. RCTs support bone density maintenance. Preferred form for women over 50.,250,1000,mg,Can be taken without food; better absorbed than carbonate in women with low stomach acid; useful for post-bariatric patients.,Yes,Bone density,No,Yes,No,No,No,Yes,Low,Head-to-head fracture outcome RCTs comparing citrate vs carbonate specifically in perimenopause are lacking.
Vitamin D3,Cholecalciferol; as Vitamin D3; Colecalciferol; Vigantol,Vitamin,Strong,"Extensive RCT and meta-analysis evidence for bone health, immune function, and mood when deficient. Evidence for reducing fracture risk is strong when combined with calcium. Some RCTs show mood benefit in deficient individuals. Perimenopause-specific bone and mood data available.",400,4000,IU,"Requires cofactors (K2, magnesium) for optimal calcium metabolism; fat-soluble so take with food; 25(OH)D blood level testing recommended before high-dose supplementation; UK NHS advises 400IU daily for general population.",Yes,Bone health,No,No,No,No,No,Yes,Low,Optimal dosing for perimenopause-specific outcomes (beyond deficiency correction) not yet established in large RCTs.
Vitamin D2,Ergocalciferol; as Vitamin D2; Ergocalciferolum,Vitamin,Some,Less potent than D3 at raising serum 25(OH)D; RCTs show it raises blood levels but less efficiently. Suitable for vegans. Most bone health RCT evidence generated with D3 form.,400,2000,IU,D3 is approximately 87% more potent than D2 at raising serum 25(OH)D levels; D2 suitable for vegans/vegetarians but D3 preferred clinically.,No,Bone health,No,No,No,No,No,Yes,Low,Comparative RCTs of D2 vs D3 specifically for perimenopause outcomes (bone mood cognition) are lacking.
Vitamin K2 MK-7,Menaquinone-7; MK-7; as Vitamin K2 MK-7; Natto-derived K2,Vitamin,Some,"RCTs show K2 MK-7 activates osteocalcin and matrix Gla protein, improving bone mineral density and reducing arterial calcification. MK-7 has longer half-life than MK-4. Perimenopause bone density RCTs exist.",90,360,mcg,Take with fat-containing meal; interacts with warfarin and anticoagulants — contraindicated; MK-7 has superior half-life (72h vs 1-2h for MK-4); 90mcg EU NRV is below therapeutic bone-protective doses used in trials.,Yes,Bone density,No,No,Yes,No,No,Yes,Low,Long-term fracture outcome RCTs specifically in perimenopausal women are lacking; optimal dose above NRV unconfirmed.
Vitamin K2 MK-4,Menatetrenone; MK-4; as Vitamin K2 MK-4,Vitamin,Some,RCTs primarily from Japan using high doses (45mg) show reduced fracture risk. Lower doses used in supplements have less evidence. MK-4 has shorter half-life requiring more frequent dosing.,1000,45000,mcg,High therapeutic doses (45mg) used in Japanese trials are far above typical supplement levels; standard supplement doses (100–200mcg) have limited supporting RCT evidence.,Yes,Bone density,No,No,Yes,No,No,Yes,Medium,Most evidence from high-dose pharmaceutical use in Japan; applicability of low-dose supplement levels unclear.
Vitamin K1,Phylloquinone; Phytonadione; as Vitamin K1,Vitamin,Some,RCT evidence mainly for coagulation and some bone support. Less cardiovascular-protective than K2 forms. Low risk of supplementation but competes with warfarin.,75,1000,mcg,Interacts with anticoagulant medications including warfarin; take with fat-containing food; K1 is primarily hepatic (clotting) while K2 acts peripherally (bone/arterial).,No,Blood clotting,No,No,Yes,No,No,Yes,Low,Limited perimenopause-specific RCTs compared to K2 forms.
Vitamin C,L-ascorbic acid; Ascorbic acid; as Vitamin C; Sodium ascorbate; Calcium ascorbate; Ester-C; ascorbyl palmitate,Vitamin,Strong,"Extensive evidence for immune function, collagen synthesis, and antioxidant activity. RCT evidence for reducing common cold duration modest. Limited perimenopause-specific trials but collagen and oxidative stress relevance is indirect.",250,2000,mg,"High doses (>1000mg) may cause GI upset; tolerable upper limit 2000mg/day; buffered forms (sodium ascorbate, Ester-C) gentler on stomach; time-release forms maintain plasma levels; take with iron to enhance non-haem absorption.",No,Immune function,No,Possible,No,No,No,Yes,Low,Perimenopause-specific RCTs measuring hot flush or hormonal outcomes are absent.
Vitamin B1,Thiamine; Thiamine HCl; Thiamine mononitrate; as Vitamin B1; Benfotiamine,Vitamin,Some,RCTs support thiamine for energy metabolism and neurological function. Benfotiamine (fat-soluble form) shows better bioavailability and neuroprotective properties. Deficiency common in women with high carbohydrate diets or alcohol use.,1,300,mg,Benfotiamine has superior bioavailability versus water-soluble thiamine HCl; water-soluble forms excreted rapidly so consistent intake important.,No,Energy metabolism,No,No,No,No,No,Yes,Low,No RCTs specifically examining thiamine supplementation in perimenopausal women.
Vitamin B2,Riboflavin; Riboflavin 5-phosphate; as Vitamin B2,Vitamin,Some,RCT evidence supports riboflavin for migraine prevention (400mg/day). Essential for energy metabolism and activating other B vitamins. May cause harmless bright yellow urine at supplement doses.,1.4,400,mg,Migraine prophylaxis requires 400mg/day — far above NRV; may be less effective in MTHFR mutation carriers who need active forms; take with food.,No,Migraine prevention,No,No,No,No,No,Yes,Low,No RCTs specifically in perimenopausal migraine sufferers.
Vitamin B3 Niacin,Niacin; Nicotinic acid; as Vitamin B3; Niacinamide; Nicotinamide,Vitamin,Strong,Strong evidence for cholesterol management at pharmacological doses (1000-3000mg). Niacinamide (nicotinamide) does not cause flushing and has some skin and joint evidence. RCT evidence at supplement doses for energy or mood is thinner.,14,3000,mg,High-dose niacin (>500mg) causes flushing — use flush-free niacinamide or extended-release forms for supplement purposes; liver toxicity possible at high doses; time-release forms have higher hepatotoxicity risk.,No,Cholesterol management,No,No,No,Yes,No,Yes,Medium,Perimenopause-specific outcomes beyond lipid management not studied in RCTs.
Vitamin B3 Niacinamide,Nicotinamide; Niacinamide; as Nicotinamide; as Niacinamide,Vitamin,Some,"RCTs show nicotinamide effective for skin conditions (acne, rosacea) and may reduce skin cancer risk. No flushing effect unlike niacin. Limited evidence for energy or cognitive benefits at supplement doses.",15,1500,mg,Does not cause niacin flush; preferred form for general supplementation; high doses (>3000mg) associated with nausea and hepatotoxicity.,No,Skin health,No,No,No,Yes,No,Yes,Low,Long-term safety data above 500mg/day in perimenopausal women is lacking.
Vitamin B5,Pantothenic acid; D-pantothenic acid; Calcium pantothenate; as Vitamin B5; Panthenol,Vitamin,Limited,Limited RCT evidence for standalone supplementation; essential for CoA synthesis and energy metabolism. Topical panthenol has strong skin evidence. No meaningful perimenopause-specific trials.,5,500,mg,Generally well tolerated; no established upper tolerable limit; deficiency is rare on balanced diet.,No,Energy metabolism,No,No,No,No,No,Yes,Low,Virtually no RCTs examining supplemental B5 for perimenopause-relevant outcomes.
Vitamin B6 Pyridoxine,Pyridoxine HCl; Pyridoxal-5-phosphate; P5P; as Vitamin B6; as Pyridoxine,Vitamin,Strong,Strong evidence for PMS symptom relief and nausea in pregnancy. RCTs support mood and hormonal balance benefits relevant to perimenopause. P5P (active form) does not require hepatic conversion. Upper tolerable limit important — neuropathy risk at high doses.,1.4,100,mg,P5P is the active coenzyme form and preferred for those with liver issues; neuropathy risk above 200mg/day long-term; EU upper tolerable limit 25mg/day; EFSA health claim approved for protein and glycogen metabolism.,Yes,PMS/mood support,Possible,No,No,No,No,No,Low,RCTs in perimenopause specifically for mood and vasomotor symptoms are limited; optimal form comparison needed.
Vitamin B7,Biotin; D-Biotin; as Vitamin B7; as Biotin,Vitamin,Limited,Limited RCT evidence for hair/nail strength at 2500-5000mcg; widely marketed but evidence for hair loss in non-deficient individuals is weak. Can interfere with thyroid and troponin immunoassay lab tests.,30,5000,mcg,"Can falsely alter thyroid hormone lab results (TSH, T4) — advise stopping 48-72h before blood tests; deficiency rare; widely over-supplemented relative to evidence base.",No,Hair and nail health,No,Yes,No,No,No,Yes,Low,No well-powered RCTs demonstrate hair growth benefit in women without biotin deficiency.
Vitamin B9 Folic Acid,Folic acid; Folate; as Vitamin B9; as Folic Acid,Vitamin,Strong,"Strong evidence for neural tube defect prevention in pregnancy. RCTs support cardiovascular and mood benefits, particularly in MTHFR variants. Perimenopause relevance includes cardiovascular protection and cognitive support. High doses may mask B12 deficiency.",200,1000,mcg,MTHFR C677T and A1298C variants impair conversion of folic acid to active methylfolate; prefer methylfolate in these populations; EU upper tolerable limit 1000mcg/day; mask B12 deficiency at high doses.,No,Pregnancy nutrition,No,No,No,No,No,Yes,Low,MTHFR variant-specific dosing guidance in perimenopausal populations not established.
Methylfolate,5-MTHF; L-methylfolate; 5-methyltetrahydrofolate; Metafolin; Quatrefolic; as Methylfolate,Vitamin,Some,"Active form of folate that bypasses MTHFR conversion step. RCTs show benefit for depression and mood, particularly in MTHFR variants. Superior to folic acid for homocysteine lowering in some populations.",200,1000,mcg,Preferred form for individuals with MTHFR variants; may cause anxiety or overstimulation in some at high doses; more expensive than folic acid but more bioavailable for at-risk groups.,No,Mood support,Possible,No,No,No,No,Yes,Low,Large RCTs comparing methylfolate vs folic acid for perimenopause mood outcomes are absent.
Vitamin B12 Cyanocobalamin,Cyanocobalamin; as Vitamin B12; as Cyanocobalamin,Vitamin,Strong,"Strong evidence for neurological function, energy metabolism, and megaloblastic anaemia prevention. Absorption declines with age due to reduced intrinsic factor. Cyanocobalamin requires hepatic conversion to active forms.",1.5,1000,mcg,Sublingual or spray forms bypass gastric absorption issues; higher doses needed as oral absorption relies on intrinsic factor which declines with age; cyanocobalamin less preferred for those with MTHFR or renal issues.,No,Neurological function,No,No,No,No,No,Yes,Low,Optimal dose and form for age-related absorption decline in perimenopausal women not established.
Vitamin B12 Methylcobalamin,Methylcobalamin; as Methylcobalamin; active B12,Vitamin,Some,Active form of B12 that does not require hepatic conversion. Evidence for neurological protection and sleep regulation. May be superior for neurological applications and those with MTHFR variants.,250,5000,mcg,Preferred for neurological applications and methylation support; sublingual form may improve absorption in individuals with intrinsic factor deficiency; more stable in formulations than hydroxocobalamin.,No,Neurological function,No,No,No,No,No,Yes,Low,Direct comparison RCTs of methylcobalamin vs cyanocobalamin for perimenopause-specific outcomes lacking.
Vitamin A Retinol,Retinol; Retinyl palmitate; Retinyl acetate; as Vitamin A; Preformed Vitamin A,Vitamin,Strong,"Essential for vision, immune function, and skin health. RCTs for supplementation mainly in deficiency populations. Teratogenic at high doses. Fat-soluble — accumulates to toxic levels.",700,3000,IU,Upper tolerable limit 3000mcg RAE (10000 IU); teratogenic — avoid high doses in women of reproductive age; fat-soluble accumulation risk with long-term supplementation; take with fat.,No,Vision support,No,No,No,Yes,No,No,Low,Toxicity threshold in perimenopausal women with concurrent high dietary retinol intake not well characterised.
Beta-Carotene,β-Carotene; Provitamin A; as Beta-Carotene,Vitamin,Some,Precursor to vitamin A; conversion rate variable (genetic and dietary factors). RCT evidence for cancer prevention largely negative (CARET trial). Antioxidant benefits at low doses. High-dose supplementation in smokers associated with increased lung cancer risk.,3,15,mg,Conversion to retinol is highly variable; does not accumulate to toxic levels like preformed vitamin A; avoid high-dose supplementation in current smokers.,No,Antioxidant activity,No,No,No,No,No,Yes,Medium,CARET trial findings on lung cancer risk in smokers limit broader use; perimenopause-specific safety data lacking.
Vitamin E Tocopherol,d-alpha-tocopherol; dl-alpha-tocopherol; Mixed tocopherols; as Vitamin E; Tocopheryl acetate,Vitamin,Some,Some RCTs show modest benefit for hot flushes and oxidative stress in perimenopause. Mixed tocopherols (including gamma-tocopherol) may be superior to alpha-tocopherol alone. High doses associated with increased bleeding risk.,100,800,IU,Natural d-alpha-tocopherol has higher bioavailability than synthetic dl-alpha-tocopherol; mixed tocopherols preferred; upper tolerable limit 1000mg/day; bleeding risk at high doses; may interact with anticoagulants.,Yes,Hot flush reduction,No,No,Yes,No,No,Yes,Low,Optimal dose and form comparison RCTs for perimenopause hot flush outcomes are limited.
Iron Bisglycinate,Ferrous bisglycinate; Ferrochel; as Iron Bisglycinate; chelated iron,Mineral,Strong,Superior bioavailability versus iron sulfate/fumarate with significantly less GI side effects. RCTs demonstrate equivalent or superior haemoglobin restoration at lower doses. Preferred form for women with iron-deficiency anaemia.,14,100,mg,"Take on empty stomach or with vitamin C for best absorption; coffee, tea, calcium reduce absorption; bisglycinate has approximately 2-4x higher bioavailability than ferrous sulfate allowing lower effective doses; do not co-supplement with calcium.",No,Iron deficiency,No,Yes,No,No,No,Yes,Low,Long-term RCTs comparing forms specifically in perimenopausal women with varying menstrual patterns are lacking.
Iron Fumarate,Ferrous fumarate; as Iron Fumarate; as Ferrous Fumarate,Mineral,Strong,Well-established form for iron deficiency anaemia. More GI side effects than bisglycinate. Widely used in NHS prescribing. Evidence base comparable to sulfate.,14,200,mg,Higher GI side effects than glycinate forms; take with food to reduce side effects at cost of some absorption; widely available and cost-effective.,No,Iron deficiency,No,Yes,No,No,No,Yes,Low,Direct head-to-head comparison with bisglycinate in perimenopausal women specifically is lacking.
Zinc Bisglycinate,Zinc bisglycinate chelate; as Zinc Bisglycinate; chelated zinc; Zinc glycinate,Mineral,Some,"Highly bioavailable form of zinc. RCTs support immune function, skin health, and hormonal balance. Zinc plays role in thyroid hormone metabolism and reproductive hormone regulation. Better tolerated than zinc sulfate.",5,40,mg,Bisglycinate has superior absorption and tolerability versus zinc sulfate or oxide; upper tolerable limit 25mg/day (UK); take with food to prevent nausea; separate from iron and calcium by 2+ hours.,No,Immune support,No,Yes,No,No,No,Yes,Low,Perimenopause-specific RCTs examining zinc's role in hormonal transitions are limited.
Zinc Gluconate,Zinc gluconate; as Zinc Gluconate,Mineral,Some,Good bioavailability form; RCTs support immune function and cold duration reduction. Commonly used in immune supplements. Similar efficacy to bisglycinate but slightly lower bioavailability.,10,40,mg,Generally well tolerated; take with food; separate from iron and calcium; chronic high doses may deplete copper — ensure adequate copper intake.,No,Immune support,No,Yes,No,No,No,Yes,Low,Comparative bioavailability studies versus bisglycinate form in older women are lacking.
Selenium Selenomethionine,L-selenomethionine; Selenium as L-selenomethionine; SeMet,Mineral,Strong,"Organic form with highest bioavailability. RCTs support thyroid function, antioxidant activity (glutathione peroxidase), and immune function. Strong evidence for thyroid health particularly in autoimmune thyroid disease. Upper limit important.",55,200,mcg,Selenomethionine has highest bioavailability of selenium forms; upper tolerable limit 400mcg/day; selenium toxicity (selenosis) above 400mcg; Brazil nuts are high natural source — supplementation risk if high nut consumption; thyroid dose usually 200mcg.,Yes,Thyroid health,No,Yes,No,No,No,Yes,Low,Optimal dose for perimenopausal thyroid health and combination with iodine not established.
Selenium Selenite,Sodium selenite; Selenious acid; as Selenium Selenite,Mineral,Some,Inorganic form; lower bioavailability than selenomethionine. RCTs show thyroid and antioxidant benefits. Adequate but not optimal form for supplementation.,55,200,mcg,Lower bioavailability than organic selenomethionine; selenomethionine preferred for supplementation; risk of interaction with vitamin C at high doses reducing absorption.,No,Thyroid health,No,Yes,No,No,No,Yes,Low,Head-to-head comparison RCTs with selenomethionine specifically for thyroid outcomes in women are limited.
Iodine,Potassium iodide; Sodium iodide; as Iodine; Kelp iodine; Lugol's iodine,Mineral,Strong,"Essential for thyroid hormone synthesis. Strong evidence for preventing hypothyroidism and goitre. UK population often mildly deficient, particularly women. Both deficiency AND excess impair thyroid function.",150,500,mcg,Upper tolerable limit 600mcg/day (EU); kelp-derived iodine has variable and often excessive content — avoid unquantified kelp sources; iodine from KI is reliable and quantified; interacts with thyroid medication and radioactive iodine treatment.,No,Thyroid function,No,Yes,No,No,Yes,Yes,Low,Optimal supplementation levels for perimenopausal women with subclinical thyroid dysfunction not established.
Chromium Picolinate,Chromium picolinate; as Chromium Picolinate; trivalent chromium,Mineral,Some,RCTs show modest benefit for glucose tolerance and insulin sensitivity. Some evidence for reducing carbohydrate cravings. Perimenopause relevance for metabolic changes and insulin resistance. Picolinate form has superior absorption.,25,1000,mcg,Picolinate form preferred for bioavailability; take with meals; evidence for weight management is inconsistent across RCTs; upper tolerable limit not well established for trivalent chromium; hexavalent chromium is carcinogenic (not present in supplements).,Yes,Blood glucose control,No,No,No,No,No,Yes,Low,Long-term RCTs for chromium supplementation in perimenopausal metabolic changes are absent.
Boron Glycinate,Boron; as Boron Glycinate; FruiteX-B; calcium fructoborate,Mineral,Limited,"Limited RCT evidence but boron influences bone metabolism, oestrogen metabolism, and cognitive function. May increase oestrogen levels in postmenopausal women. Fruit form (calcium fructoborate) has proprietary study data.",1,10,mg,Doses above 20mg/day may cause toxicity; FruiteX-B (calcium fructoborate) has more human study data than boron glycinate; potential oestrogenic effect warrants caution in hormone-sensitive conditions.,Yes,Bone metabolism,No,No,No,No,Yes,Unknown,Low,Limited independent RCTs; most evidence from small or industry-funded studies.
Copper Gluconate,Copper bisglycinate; as Copper Gluconate; as Copper; cupric gluconate,Mineral,Some,Essential micronutrient; RCTs limited as deficiency is rare. Important cofactor for iron metabolism — high-dose zinc supplementation depletes copper. Copper: zinc ratio important for cardiovascular health.,0.5,3,mg,Upper tolerable limit 5mg/day; commonly depleted by high-dose zinc (>40mg); supplement 1mg copper per 15mg zinc above maintenance levels; copper deficiency can cause neurological symptoms.,No,Metabolic cofactor,No,No,No,No,No,Yes,Low,RCTs specifically examining copper supplementation in perimenopausal women are absent.
Manganese Bisglycinate,Manganese; as Manganese Bisglycinate; manganese chelate,Mineral,Limited,"Essential for bone matrix formation and antioxidant superoxide dismutase. Limited standalone RCT evidence; frequently included in bone health formulas with calcium, D3, and K2.",1,11,mg,Upper tolerable limit 11mg/day; generally included in small doses as bone cofactor; bisglycinate form preferred for bioavailability.,No,Bone cofactor,No,No,No,No,No,Yes,Low,No standalone RCTs for perimenopausal bone health outcomes.
Creatine Monohydrate,Creatine; Creatine monohydrate; CreaPure; as Creatine Monohydrate,Performance,Strong,"Strong RCT evidence for muscle strength and power in both athletes and older adults. Emerging RCT evidence for cognitive function, mood, and bone density in women. Meta-analyses support lean mass preservation. Recent evidence specifically in perimenopausal and postmenopausal women is growing.",3,20,g,Loading phase (20g/day for 5 days) increases stores faster but causes water retention; 3-5g/day maintenance is sufficient for most; micronised forms improve dissolution; most cost-effective as monohydrate; take post-exercise or with carbohydrates for best muscle uptake.,Yes,Muscle strength,No,No,No,No,No,Yes,Low,Post-2022: emerging RCT evidence specifically in perimenopausal women for cognitive and bone outcomes; long-term studies >12 months in this population needed.
Coenzyme Q10 Ubiquinone,CoQ10; Ubiquinone; Ubidecarenone; as CoQ10; as Ubiquinone,Performance,Strong,"Multiple RCTs support benefits for cardiovascular health, statin-induced myopathy relief, and energy metabolism. Evidence for fertility support in older reproductive-age women. Endogenous CoQ10 production declines with age. Statins significantly deplete CoQ10.",30,300,mg,Fat-soluble — must be taken with a fatty meal; ubiquinol form may be superior for absorption in individuals over 40; soft-gel formulations improve bioavailability; divide doses if taking >100mg.,Yes,Cardiovascular health,No,No,No,No,No,Yes,Low,Optimal form comparison (ubiquinone vs ubiquinol) specifically for perimenopausal outcomes not settled.
Coenzyme Q10 Ubiquinol,Ubiquinol; reduced CoQ10; Kaneka Ubiquinol; as Ubiquinol,Performance,Some,Active reduced form of CoQ10; some RCTs suggest superior absorption particularly in older adults and those with mitochondrial dysfunction. Less oxidised during digestion. Evidence base smaller than ubiquinone.,50,300,mg,May have superior bioavailability in older adults compared to ubiquinone; more expensive; fat-soluble — take with food; limited head-to-head RCTs versus ubiquinone for clinical outcomes.,Yes,Energy metabolism,No,No,No,No,No,Yes,Low,Direct comparison RCTs of ubiquinol vs ubiquinone specifically in perimenopausal women are lacking.
Alpha Lipoic Acid,ALA; R-lipoic acid; S-lipoic acid; R-ALA; as Alpha Lipoic Acid; thioctic acid,Performance,Some,"RCTs support benefits for insulin sensitivity, neuropathy, and antioxidant activity. R-ALA is the biologically active form. Some evidence for weight management in PCOS. Limited perimenopause-specific trials.",100,600,mg,R-ALA form is more bioavailable than racemic mixture; take on empty stomach for best absorption; may lower blood glucose — caution in diabetics; interact with thyroid medication and chemotherapy.,No,Antioxidant activity,No,Yes,No,No,No,Yes,Low,Perimenopause-specific RCTs examining ALA for metabolic and neuroprotective outcomes are lacking.
Resveratrol,Trans-resveratrol; Polygonum cuspidatum extract; as Resveratrol; Japanese knotweed,Performance,Limited,RCT evidence for cardiovascular and metabolic benefits is inconsistent. Low oral bioavailability limits efficacy of many products. Some RCTs in postmenopausal women show cognitive and cardiovascular benefits. Recent evidence mixed.,75,500,mg,Very low bioavailability (~1%); micronised forms or combination with piperine may improve absorption; anti-oestrogenic and pro-oestrogenic effects documented depending on concentration — caution in hormone-sensitive conditions.,Yes,Antioxidant activity,No,No,No,Yes,Yes,Unknown,Medium,Conflicting RCT results; bioavailability challenge limits translation from preclinical data; long-term safety in oestrogen-sensitive individuals not established.
NMN,Nicotinamide mononucleotide; β-NMN; as NMN,Performance,Limited,Early phase human RCTs show NMN raises blood NAD+ levels and may improve muscle insulin sensitivity and aerobic capacity in older adults. Evidence base is very young and most RCTs are small and short-term. Post-2022 data growing.,125,1200,mg,Post-2022: several small RCTs have now been published showing NAD+ elevation; long-term safety data absent; currently in regulatory grey area in some jurisdictions; FDA has raised questions about NMN's status as a dietary supplement vs investigational drug.,No,NAD+ precursor,No,No,No,No,No,Unknown,High,Post-2022: FDA challenged NMN's supplement status; long-term safety and efficacy RCTs absent; regulatory status uncertain in UK/EU.
NAD+,Nicotinamide adenine dinucleotide; as NAD+; reduced NAD,Performance,None,Oral NAD+ has very poor bioavailability due to degradation before absorption. No meaningful human RCT evidence for oral NAD+ supplementation. NMN and NR are preferred precursor strategies.,100,500,mg,Direct oral NAD+ is unlikely to significantly raise systemic NAD+ levels due to poor bioavailability; NMN and NR are more clinically rational approaches.,No,NAD+ support,No,No,No,No,No,Unknown,Low,Fundamental bioavailability questions mean no meaningful clinical RCT base exists.
Nicotinamide Riboside,NR; Niagen; as Nicotinamide Riboside; as NR,Performance,Some,Multiple small RCTs confirm NR raises blood NAD+ levels. Some RCTs show metabolic and cardiovascular benefits. Evidence base more established than NMN. Short-term safety appears acceptable.,100,1000,mg,Currently considered a dietary supplement in UK/EU; multiple branded forms available (Niagen); divided doses may maintain NAD+ levels more consistently; long-term safety data beyond 12 months lacking.,No,NAD+ precursor,No,No,No,No,No,Unknown,Medium,Long-term safety data and perimenopause-specific clinical outcomes not yet established.
Berberine,Berberine HCl; as Berberine; Berberine chloride; Goldenseal berberine,Performance,Strong,"Multiple RCTs demonstrate berberine comparable to metformin for blood glucose control in T2DM. Evidence for PCOS, cardiovascular, and gut health. MHRA enforcement risk in UK as unlicensed medicine claims. Significant drug interactions.",500,1500,mg,"Take with meals to reduce GI side effects; interacts with metformin, cyclosporine, CYP3A4 substrates; may reduce oral contraceptive efficacy; should not be used as unlicensed substitute for prescribed diabetes treatment; MHRA may classify as medicinal.",Yes,Blood glucose control,No,No,No,Yes,No,No,High,MHRA regulatory risk in UK for medicinal claims; drug interaction profile significant; perimenopause-specific RCTs needed.
PQQ,Pyrroloquinoline quinone; PQQ disodium salt; BioPQQ; as PQQ,Performance,Limited,Very limited human RCT data. Small trials suggest cognitive and mitochondrial energy benefits. Preclinical evidence strong but human translation limited. Safety appears acceptable at low doses.,10,20,mg,Very limited human RCT data; most evidence from animal studies; 10-20mg doses used in available human trials; long-term safety data absent.,No,Mitochondrial support,No,No,No,No,No,Unknown,Low,Almost no robust human RCT evidence; translation from preclinical data to clinical benefit unestablished.
Astaxanthin,Natural astaxanthin; Haematococcus pluvialis extract; as Astaxanthin,Performance,Some,"RCTs show antioxidant, skin, and eye health benefits. Some cardiovascular evidence. Anti-inflammatory properties studied in small RCTs. Generally well tolerated.",4,12,mg,Fat-soluble — take with food; natural (algae-derived) astaxanthin more bioavailable than synthetic; most RCTs use 4-12mg doses; no established upper tolerable limit.,No,Antioxidant activity,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs are absent; optimal dosing for skin and cognitive outcomes in women 40-55 not established.
Lutein,Lutein; FloraGLO Lutein; as Lutein; Carotenoid,Performance,Strong,Multiple RCTs support lutein for macular degeneration prevention and eye health (AREDS2 trial). Some evidence for cognitive function. Fat-soluble carotenoid.,6,20,mg,Fat-soluble — take with food; free form lutein (vs lutein ester) may have more predictable bioavailability; found naturally in egg yolks and leafy greens.,No,Eye health,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs for cognitive benefit are limited; most evidence from older populations.
Zeaxanthin,Zeaxanthin; RR-zeaxanthin; Optisharp; as Zeaxanthin,Performance,Strong,Strong evidence alongside lutein from AREDS2 for macular degeneration prevention. Often combined with lutein in eye health supplements.,2,10,mg,Usually combined with lutein in a 5:1 (lutein:zeaxanthin) ratio; fat-soluble — take with food.,No,Eye health,No,No,No,No,No,Yes,Low,Standalone perimenopause-specific RCTs absent.
Lycopene,Lycopene; Tomato extract; as Lycopene,Performance,Some,Some RCTs for prostate health (primarily male evidence). Female data limited — some cardiovascular and skin benefits. Largely safe at dietary supplement doses.,7,75,mg,Fat-soluble; cooked tomato products have higher lycopene bioavailability than raw; may weakly reduce anticoagulant effects.,No,Antioxidant activity,No,No,No,No,No,Yes,Low,Female-specific perimenopause RCTs are almost entirely absent.
Omega-3 EPA,EPA; Eicosapentaenoic acid; Fish oil EPA; as Omega-3 EPA; Icosapentaenoic acid,Fatty Acid,Strong,"Multiple RCTs and meta-analyses support EPA for cardiovascular health, triglyceride reduction, and anti-inflammatory effects. Some evidence for mood and depression, particularly EPA-dominant formulas. Perimenopause relevance for cardiovascular risk and mood.",500,4000,mg,Enteric coating reduces fishy burps; take with food; anticoagulant effect at doses above 3g/day — caution with warfarin; oxidation important — choose quality assured products; prescription-strength EPA (Vascepa/Icosapent ethyl) distinct from supplement EPA.,Yes,Cardiovascular health,Possible,No,Yes,No,No,Yes,Low,Optimal EPA:DHA ratio for perimenopausal mood and cardiovascular outcomes not established.
Omega-3 DHA,DHA; Docosahexaenoic acid; Fish oil DHA; as Omega-3 DHA; Algal DHA,Fatty Acid,Strong,"Strong RCT evidence for cognitive development, eye health, and cardiovascular benefits. Algal DHA available as vegan source. Important for brain health and myelin maintenance. Perimenopause cognitive benefit evidence emerging.",200,3000,mg,Vegan algal DHA is equivalent bioavailability to fish oil DHA; enteric coating reduces fishy burps; anticoagulant effect at high doses; DHA more important for cognitive applications; EPA more important for mood/cardiovascular.,Yes,Cognitive support,Possible,No,Yes,No,No,Yes,Low,Perimenopause-specific RCTs for cognitive outcomes comparing EPA vs DHA-dominant formulas are limited.
GLA,Gamma-linolenic acid; Evening Primrose Oil GLA; Borage oil GLA; as GLA,Fatty Acid,Some,"RCTs show benefit for PMS, breast pain (mastalgia), and skin hydration. Some evidence for hot flush reduction in perimenopause from evening primrose oil RCTs. Evidence less consistent than omega-3.",240,3000,mg,Source matters — borage oil has higher GLA content than evening primrose; take with food; may mildly inhibit platelet aggregation at high doses; beneficial effects typically require 6-8 weeks supplementation.,Yes,Breast pain relief,No,No,Possible,No,Yes,Yes,Low,Head-to-head RCTs comparing GLA sources (EPO vs borage) for perimenopause outcomes are limited.
ALA Omega-3,Alpha-linolenic acid; ALA; Flaxseed oil ALA; as ALA; as Alpha-Linolenic Acid,Fatty Acid,Some,"Plant-based omega-3 precursor; conversion to EPA/DHA is poor (~5-10% to EPA, <1% to DHA). RCTs show cardiovascular benefits but weaker than preformed EPA/DHA. Important for vegans.",1100,3000,mg,Very poor conversion to long-chain EPA/DHA; recommended as adjunct to EPA/DHA rather than replacement; flaxseed oil is richest ALA source; does not substitute for preformed EPA/DHA for cognitive or mood applications.,No,Cardiovascular support,No,No,No,No,No,Yes,Low,Conversion efficiency variation between individuals not well characterised; insufficient substitute for EPA/DHA in perimenopause.
Phosphatidylserine,PS; Soy-derived PS; Sunflower PS; as Phosphatidylserine,Fatty Acid,Strong,"Multiple RCTs show cognitive benefits, particularly for memory, attention, and mood. Evidence for HPA axis modulation and cortisol reduction. Perimenopause relevance for cognitive decline prevention and stress response. Originally bovine-derived; now soy or sunflower.",100,400,mg,Soy and sunflower-derived PS widely used; bovine-derived PS no longer used due to BSE; take with food; some evidence for improved cognitive outcomes in mild cognitive impairment; typically 100-400mg/day in RCTs.,Yes,Cognitive function,No,No,No,No,No,Yes,Low,Long-term RCTs specifically in perimenopausal women for cognitive and mood outcomes are lacking.
Phosphatidylcholine,PC; Lecithin PC; as Phosphatidylcholine; Alpha-GPC precursor,Fatty Acid,Some,"Important for cell membrane integrity, liver health, and acetylcholine synthesis. RCTs show benefit for non-alcoholic fatty liver disease. Cognitive applications less well studied than phosphatidylserine.",250,900,mg,Found in lecithin (soy or sunflower); component of Alpha-GPC; choline conversion important for methylation; take with food.,No,Liver health,No,No,No,No,No,Yes,Low,Perimenopause-specific cognitive RCTs are lacking.
Lecithin,Soy lecithin; Sunflower lecithin; as Lecithin,Fatty Acid,Limited,Contains phosphatidylcholine and other phospholipids. Limited standalone RCT evidence but provides dietary choline. Used in emulsification. Some evidence for cognitive and liver benefits.,1200,7200,mg,Sunflower lecithin preferred over soy for those with soy sensitivity; contains approximately 15-25% phosphatidylcholine; quality and standardisation varies between products.,No,Choline source,No,No,No,No,No,Yes,Low,Insufficient standalone RCTs to assess clinical impact separate from constituent phospholipids.
L-Theanine,L-theanine; Suntheanine; as L-Theanine; gamma-glutamylethylamide,Amino Acid,Strong,"Multiple RCTs demonstrate L-theanine promotes relaxation without sedation, reduces anxiety, improves sleep quality, and enhances cognitive performance especially when combined with caffeine. Perimenopause relevance for anxiety, sleep, and cognitive fog.",100,400,mg,Often combined with caffeine in a 2:1 ratio (theanine:caffeine) for cognitive enhancement; well tolerated; no known toxicity; Suntheanine is patented L-form; effects within 30-60 minutes for acute anxiety relief.,Yes,Relaxation and focus,No,No,No,No,No,Yes,Low,Long-term RCTs specifically examining perimenopause anxiety and cognitive outcomes are limited.
5-HTP,5-hydroxytryptophan; L-5-HTP; as 5-HTP; Griffonia simplicifolia extract,Amino Acid,Some,"RCTs show benefits for depression, anxiety, sleep, and appetite regulation through serotonin precursor action. Perimenopause relevance for mood, sleep, and hot flush frequency. Serotonin system implicated in vasomotor symptoms.",50,300,mg,CONTRAINDICATED with SSRIs and MAOIs due to serotonin syndrome risk; take 30 minutes before bed for sleep; some evidence for hot flush reduction; start at 50mg to assess tolerance; European natural medicine guidance supports use.,Yes,Mood support,Yes,No,No,No,No,Unknown,Medium,Serotonin syndrome risk with concurrent SSRI use requires strong prescriber guidance; perimenopause-specific long-term RCTs lacking.
Tryptophan,L-tryptophan; as L-Tryptophan; as Tryptophan,Amino Acid,Some,Serotonin and melatonin precursor. RCTs show benefit for sleep onset and mood. Less potent than 5-HTP but may be better tolerated. EMS outbreak history from contaminated batch in 1989 — high-quality sourcing critical.,500,2000,mg,CAUTION with SSRIs — potential serotonin syndrome; take at night with carbohydrates to improve CNS uptake; EMS (eosinophilia-myalgia syndrome) historically linked to contaminated batches; current regulations require pharmaceutical-grade sourcing.,Yes,Sleep support,Yes,No,No,No,No,Unknown,Medium,Perimenopause-specific RCTs for hot flush and sleep outcomes limited; manufacturing quality concerns persist historically.
GABA,Gamma-aminobutyric acid; as GABA; PharmaGABA,Amino Acid,Limited,"Oral GABA has poor blood-brain barrier penetration, limiting CNS efficacy of oral supplementation. PharmaGABA (naturally fermented form) shows some limited sleep and relaxation evidence. Mechanism of action for oral GABA in brain is debated.",100,750,mg,Blood-brain barrier penetration is disputed; PharmaGABA may work via gut-brain axis or peripheral mechanisms; generally well tolerated; L-theanine and glycine may be more evidence-based alternatives for sleep/anxiety.,No,Relaxation,No,No,No,No,No,Yes,Low,Fundamental questions about oral bioavailability and CNS penetration remain unresolved.
Glycine,Glycine; as Glycine; amino acid glycine,Amino Acid,Some,RCTs show glycine (3g before bed) improves subjective sleep quality and reduces fatigue. Anti-inflammatory and collagen synthesis roles. Generally very well tolerated and inexpensive.,1500,5000,mg,3g before bed for sleep evidence; component of collagen (one-third of collagen amino acid content); well tolerated; can be added to hot drinks easily; synergistic with magnesium glycinate formulations.,Yes,Sleep quality,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs for sleep and cognitive outcomes are lacking.
NAC,N-acetyl cysteine; N-acetylcysteine; as NAC,Amino Acid,Strong,"Strong evidence for liver protection (paracetamol overdose treatment, standard of care). RCTs show benefits for PCOS, OCD, addiction, and respiratory conditions. Antioxidant via glutathione synthesis. Post-2022: MHRA and FDA reviewed supplement status.",600,2400,mg,Post-2022: FDA and MHRA have scrutinised NAC's supplement status as it is also a licensed medicine (used for paracetamol overdose); UK regulatory status in flux; separate from food supplements to medicines review; avoid in active peptic ulcer.,No,Antioxidant/liver,No,No,No,No,No,Unknown,High,Post-2022: regulatory status under review by FDA and MHRA; may not remain freely available as supplement; perimenopause-specific RCTs lacking.
L-Carnitine,Carnitine; L-carnitine; as L-Carnitine; carnitine tartrate,Amino Acid,Some,"RCTs support L-carnitine for energy metabolism, fatigue reduction, and fertility (particularly in women with PCOS). Evidence for cognitive benefits modest. More relevant in deficiency or high-demand states.",500,3000,mg,L-carnitine and acetyl-L-carnitine have different tissue distributions; carnitine tartrate commonly used in supplements for stability; vegetarians/vegans have lower baseline carnitine and may benefit more.,No,Energy metabolism,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs examining fatigue and energy outcomes are lacking.
Acetyl-L-Carnitine,ALCAR; Acetyl-L-carnitine; as Acetyl-L-Carnitine; ALC,Amino Acid,Some,"RCTs show cognitive benefits, particularly in mild cognitive impairment and depression in older adults. Crosses blood-brain barrier more effectively than L-carnitine. Neuroprotective properties.",500,2000,mg,Preferred for cognitive applications due to superior blood-brain barrier penetration; may support acetylcholine synthesis; mild interactions possible with anticoagulants (case reports).,No,Cognitive support,No,No,Possible,No,No,Yes,Low,Perimenopause-specific cognitive RCTs are absent.
Taurine,Taurine; as Taurine; 2-aminoethanesulfonic acid,Amino Acid,Some,"RCTs show cardiovascular, blood pressure, and exercise performance benefits. Some evidence for anxiety and sleep. Generally very well tolerated. Widely present in energy drinks at doses studied in RCTs.",500,3000,mg,Well tolerated; no established upper tolerable limit; may augment effects of GABA-ergic sedatives; widely available and inexpensive.,No,Cardiovascular support,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs are absent; optimal dosing for multiple outcomes not defined.
L-Tyrosine,Tyrosine; L-tyrosine; as L-Tyrosine; N-acetyl-L-tyrosine,Amino Acid,Some,"RCTs show benefit for cognitive performance under stress, sleep deprivation, and cold stress. Thyroid hormone precursor (converted to T3/T4). Relevant to perimenopausal cognitive and stress symptoms.",500,2000,mg,Thyroid hormone precursor — may affect thyroid medication requirements; take on empty stomach for best uptake; N-acetyl tyrosine has variable bioavailability; avoid in phenylketonuria; caution with MAOI and some thyroid medications.,No,Cognitive performance,No,Yes,No,No,No,Yes,Low,Perimenopause-specific RCTs examining cognitive and thyroid interactions are lacking.
L-Lysine,Lysine; L-lysine HCl; as L-Lysine,Amino Acid,Some,RCTs support lysine for herpes simplex virus (cold sore) suppression and calcium absorption. Essential amino acid; component of collagen. Anti-anxiety properties in some limited RCTs.,500,3000,mg,Commonly combined with arginine — high arginine intake may counteract lysine's herpes-suppressing effect; well tolerated; component of collagen cross-linking.,No,Collagen synthesis,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs are largely absent.
L-Arginine,Arginine; L-arginine HCl; as L-Arginine,Amino Acid,Some,"RCTs support arginine for cardiovascular function via nitric oxide synthesis, erectile dysfunction (male evidence primarily), and exercise performance. Some female sexual function evidence. May worsen herpes outbreaks.",1000,6000,mg,May worsen herpes simplex outbreaks; take on empty stomach; may interact with blood pressure medications and PDE5 inhibitors; high doses can cause GI upset.,No,Cardiovascular support,No,No,No,No,No,Yes,Low,Female sexual function RCTs in perimenopausal women using arginine are very limited.
L-Glutamine,Glutamine; L-glutamine; as L-Glutamine,Amino Acid,Some,"RCTs support gut integrity (leaky gut), post-surgical recovery, and immune function. Most evidence in clinical settings rather than healthy supplementation. Gut lining support is main evidence-based application.",5000,40000,mg,Take between meals for gut mucosal uptake; very well tolerated; most evidence in clinical/medical nutrition contexts rather than general wellness.,No,Gut integrity,No,No,No,No,No,Yes,Low,General wellness applications in healthy perimenopausal women not supported by strong RCT data.
Proline,L-proline; as L-Proline,Amino Acid,Limited,Collagen amino acid; limited standalone RCT evidence. Important for wound healing and skin structure. Usually supplied via collagen hydrolysate rather than standalone supplementation.,500,5000,mg,Usually provided through collagen peptide supplements; isolated supplementation is uncommon in clinical practice; well tolerated.,No,Collagen synthesis,No,No,No,No,No,Yes,Low,No meaningful standalone RCTs; evidence derived from collagen peptide studies.
Hydroxyproline,Hydroxyl-L-proline; as Hydroxyproline; trans-4-Hydroxy-L-proline,Amino Acid,Limited,Collagen-specific amino acid; urinary hydroxyproline used as collagen breakdown marker. Minimal standalone supplementation evidence; provided through collagen hydrolysate.,500,3000,mg,No standalone supplement evidence; present in collagen hydrolysates; hydroxyproline-containing dipeptides may mediate collagen synthesis signalling.,No,Collagen marker,No,No,No,No,No,Yes,Low,No meaningful standalone RCT evidence; effects derived from collagen peptide research.
Collagen Type I,Bovine collagen Type I; Marine collagen Type I; Hydrolysed collagen Type I; as Collagen Type I; collagen peptides,Structural Protein,Some,"RCTs show benefit for skin elasticity, hydration, and wrinkle reduction. Some evidence for nail and hair strength. Perimenopause relevance: oestrogen decline accelerates collagen loss. Hydrolysed forms show better absorption. Post-2022 data growing.",2500,15000,mg,Hydrolysed collagen peptides (3-10kDa) have superior absorption; marine collagen (fish-derived) Type I most abundant; take with vitamin C to support collagen synthesis; evidence primarily for skin — bone/joint evidence mainly from Type II.,Yes,Skin elasticity,No,No,No,No,No,Yes,Low,Post-2022: growing evidence base but optimal dose/source/peptide size for perimenopausal women not established.
Marine Collagen,Fish collagen; Marine collagen peptides; Peptan; as Marine Collagen,Structural Protein,Some,"Predominantly Type I collagen from fish skin/scales. RCTs show skin, nail, and hair benefits. Sustainable and highly bioavailable source. Well tolerated; avoid in fish allergies.",2500,10000,mg,Fish allergy contraindication; typically bovine collagen is alternative; Peptan is well-studied branded marine collagen; take with vitamin C; hydrolysed forms best absorbed.,Yes,Skin health,No,No,No,No,No,Yes,Low,Head-to-head comparison with bovine collagen for perimenopause-specific outcomes not available.
Bovine Collagen,Beef collagen; Bovine collagen peptides; as Bovine Collagen; collagen types I and III,Structural Protein,Some,Contains both Type I and Type III collagen; RCTs support skin joint and bone benefits. Well tolerated. Avoid in beef allergies. Most widely studied collagen type in joint health.,5000,15000,mg,Avoid in beef allergies; contains both Type I (skin) and Type III (skin blood vessels); pasture-raised/grass-fed sourcing is quality marker; take with vitamin C.,Yes,Skin and joint health,No,No,No,No,No,Yes,Low,Long-term RCTs (>12 months) for bone outcomes specifically in perimenopausal women needed.
Collagen Type II,Chicken sternum collagen; as Collagen Type II; UC-II; undenatured Type II collagen,Structural Protein,Some,UC-II (undenatured Type II collagen) RCTs show joint cartilage and osteoarthritis benefits via oral tolerance mechanism at very low doses. Different mechanism and dose than hydrolysed collagen. Limited perimenopause bone-specific data.,10,40,mg,UC-II mechanism operates at very low dose (40mg/day); mechanism is immune tolerance not amino acid supply — do not increase dose expecting greater benefit; different application from Type I/III hydrolysed collagen.,No,Joint health,No,No,No,No,No,Yes,Low,Perimenopause joint health RCTs specifically are limited.
Collagen Type III,as Collagen Type III; bovine skin collagen III,Structural Protein,Limited,"Type III collagen found in skin, blood vessels, and organs. Limited standalone evidence; usually provided alongside Type I in bovine collagen. Important for skin suppleness and vascular integrity.",2500,10000,mg,Rarely supplemented in isolation; present in bovine collagen supplements; evidence attributed to Type I + III combination.,No,Skin structure,No,No,No,No,No,Yes,Low,No standalone RCTs; effects attributed to mixed collagen type supplements.
Hyaluronic Acid,HA; Hyaluronan; Sodium hyaluronate; as Hyaluronic Acid,Structural Protein,Some,Oral HA RCTs show skin hydration joint lubrication and eye dryness improvements. Perimenopause relevance for skin changes and joint discomfort. Topical evidence stronger than oral but oral evidence growing.,80,200,mg,Oral bioavailability historically questioned but recent RCTs support effectiveness; lower molecular weight forms may have superior bioavailability; take with food; topical application has stronger evidence than oral for skin outcomes.,Yes,Skin hydration,No,No,No,No,No,Yes,Low,Optimal molecular weight and dose for oral perimenopause outcomes (skin joints vaginal dryness) not established.
Elastin Peptides,Elastin hydrolysate; as Elastin Peptides; BioElastin,Structural Protein,Limited,Very limited RCT evidence. Small studies suggest skin elasticity and joint benefits. Emerging area with limited independent research.,100,500,mg,Very limited clinical data; usually combined with collagen peptides in anti-ageing formulas; most evidence from manufacturer-funded studies.,No,Skin elasticity,No,No,No,No,No,Yes,Low,Almost no independent robust RCT evidence exists.
Black Cohosh,Actaea racemosa; Cimicifuga racemosa; as Black Cohosh; Remifemin,Botanical,Strong,"Most studied botanical for menopause symptoms. Multiple RCTs and meta-analyses show significant reduction in hot flushes, night sweats, and mood symptoms. Evidence specifically in perimenopausal and menopausal women. Mechanism not clearly oestrogenic.",20,160,mg,Remifemin (Schaper & Brümmer) is best-studied standardised extract; standardised to triterpene glycosides; effects take 4-8 weeks; maximum 6-month continuous use recommended due to rare hepatotoxicity risk; discontinue if jaundice occurs.,Yes,Hot flush reduction,No,No,No,Yes,No,Unknown,Low,Long-term safety data (>6 months) and safety in oestrogen-sensitive cancers remain uncertain.
Red Clover Isoflavones,Trifolium pratense; as Red Clover; Promensil; Biochanin A; Formononetin; Daidzein; Genistein,Botanical,Some,Multiple RCTs show modest reduction in hot flush frequency; Promensil (standardised red clover isoflavone) has most evidence. Weaker effect than HRT. Phytoestrogenic activity — caution in oestrogen-sensitive conditions.,40,160,mg,"Phytoestrogenic — avoid in oestrogen-sensitive cancers (breast, endometrial) or with oestrogen-dependent conditions; effects take 8-12 weeks; Promensil and Menoflavon are best-studied standardised extracts; interacts with tamoxifen.",Yes,Hot flush reduction,No,No,No,No,Yes,No,Medium,Safety in women with oestrogen-sensitive cancer or family history not established; long-term endometrial safety data limited.
Soy Isoflavones,Daidzein; Genistein; Glycitein; Soy isoflavones; as Soy Isoflavones; equol,Botanical,Some,"RCTs show modest hot flush reduction, particularly in women who are equol producers (~30-50% of Western women). Variable response based on gut microbiome equol conversion. Bone density evidence exists.",40,100,mg,Equol production (from daidzein) determines clinical response — non-producers benefit less; phytoestrogenic — caution in oestrogen-sensitive conditions; Asian dietary evidence does not directly translate to supplementation in Western populations.,Yes,Hot flush reduction,No,No,No,No,Yes,No,Medium,Individual response variation based on equol-producer status makes universal dosing challenging.
Sage Leaf,Salvia officinalis; as Sage Leaf; garden sage; Salvia extract,Botanical,Some,RCTs show significant reduction in hot flush and night sweat frequency in perimenopausal women. Small number of good-quality trials. Fresh sage extract and standardised dried sage show similar effects. Well tolerated at studied doses.,300,800,mg,Fresh sage leaf extract (Menosan/Menoforce) has most evidence; standardised preparations preferred; raw sage essential oil contains thujone — avoid essential oil internally; therapeutic doses of sage may mildly affect thyroid hormones; effects within 4 weeks.,Yes,Hot flush reduction,No,Possible,No,No,No,Unknown,Low,Limited number of independent RCTs; optimal dose and long-term safety not established.
Ashwagandha KSM-66,Withania somnifera; KSM-66; as Ashwagandha; Indian ginseng; Sensoril; Winter cherry,Botanical,Strong,"Multiple RCTs with KSM-66 extract show reduced cortisol, anxiety, thyroid support, and sexual function improvement in women. Growing perimenopause-specific evidence for stress, sleep, and sexual function.",240,600,mg,KSM-66 (5% withanolides) and Sensoril (10% withanolides) are best-studied standardised extracts; KSM-66 more commonly studied for sexual function and energy; Sensoril for stress/anxiety; effects within 8 weeks; avoid in autoimmune conditions; may affect thyroid — monitor TSH in hypothyroid patients.,Yes,Stress reduction,No,Yes,No,No,Yes,No,Low,Post-2022: new RCTs specifically in perimenopausal women for sexual function and sleep published; MHRA monitoring autoimmune and thyroid interactions.
Maca Root,Lepidium meyenii; as Maca; Peruvian ginseng; gelatinised maca; black maca; red maca,Botanical,Some,"RCTs specifically in perimenopausal and menopausal women show improvements in sexual function, energy, mood, and reduction in anxiety and depression. Hormonal mechanism debated — may be adaptogenic rather than directly oestrogenic.",1500,3000,mg,"Gelatinised maca preferred for digestibility; black, red, and yellow maca have different compositions; most RCTs use 2-3.5g/day; effects take 6-12 weeks; generally well tolerated; no clear oestrogenic activity in RCTs despite traditional use in hormonal conditions.",Yes,Sexual function,No,No,No,No,Possible,Yes,Low,Standardisation of maca preparations varies widely; optimal maca type and dose for specific perimenopausal outcomes not established.
Shatavari,Asparagus racemosus; as Shatavari,Botanical,Limited,"Ayurvedic herb with limited but promising RCT evidence for menopausal symptoms, galactagogue activity, and female reproductive health. Phytoestrogenic activity studied. Limited Western clinical trial data.",250,1000,mg,Phytoestrogenic activity — caution in oestrogen-sensitive conditions; limited standardisation of extracts; most evidence from Indian Ayurvedic medicine research with variable quality.,Yes,Hormonal balance,No,No,No,No,Yes,Unknown,Medium,Very limited independent Western RCT data; standardisation of preparations poorly defined.
Dong Quai,Angelica sinensis; as Dong Quai; Female ginseng; Chinese angelica,Botanical,Limited,Limited RCT evidence for menopausal symptoms; some traditional Chinese medicine trial evidence. Contains furanocoumarins - photosensitivity and anticoagulant interaction risk. Oestrogenic activity debated.,100,600,mg,Contains furanocoumarins - photosensitivity risk; anticoagulant interaction (warfarin aspirin); oestrogen-sensitive conditions contraindicated; quality and standardisation of extracts varies significantly.,Yes,Hormonal support,No,No,Yes,No,Yes,No,Medium,Reliable independent RCT evidence very limited; safety profile poorly characterised in modern populations.
Chasteberry,Vitex agnus-castus; as Chasteberry; Chaste tree berry; Agnus castus,Botanical,Strong,Multiple RCTs and meta-analysis support chasteberry for PMS and cycle irregularity. Acts on dopamine and prolactin pathways. Perimenopause relevance for cycle regulation and mood. Not oestrogenic.,20,40,mg,Acts on dopamine D2 receptors to reduce prolactin; Agnucaston and Mastodynon are most-studied standardised preparations; not suitable with dopamine-affecting medications; contraindicated in prolactin-dependent tumours.,Yes,PMS/cycle support,No,No,No,No,No,No,Low,Limited long-term RCTs in perimenopausal women specifically; interaction with hormone therapies not fully characterised.
Evening Primrose Oil,EPO; Oenothera biennis; as Evening Primrose Oil; GLA source; efamol,Botanical,Some,"RCTs show modest benefit for hot flushes, PMS, and breast pain. Contains GLA as active component. Evidence for hot flush reduction weaker than black cohosh but well tolerated.",500,3000,mg,Source of GLA; effects take 6-8 weeks; may mildly inhibit platelet aggregation at high doses; anticoagulant caution; perimenopause hot flush evidence from small RCTs.,Yes,Hot flush support,No,No,Possible,No,No,Yes,Low,Hot flush evidence limited to small RCTs; larger definitive trials lacking.
Valerian Root,Valeriana officinalis; as Valerian Root; valerian extract; Valdispert,Botanical,Some,Multiple RCTs and a Cochrane review show modest benefit for sleep onset and sleep quality. Evidence for anxiety and menopausal sleep specifically also exists. Effect size modest. Well tolerated.,300,600,mg,"Takes 2-4 weeks for full effect; standardised to valerenic acid (0.8%); may cause mild sedation — caution when driving; avoid with alcohol, benzodiazepines, or other sedatives; discontinue 2 weeks before surgery.",Yes,Sleep improvement,No,No,No,Yes,No,Yes,Low,Optimal dose and long-term effectiveness in perimenopausal women specifically not established.
Passionflower,Passiflora incarnata; as Passionflower; maypop,Botanical,Some,RCTs show anxiolytic and sleep benefits. Comparable to low-dose benzodiazepines in some small RCTs. Generally well tolerated. Limited perimenopause-specific data.,200,400,mg,May cause mild sedation — avoid with sedative medications; generally well tolerated; extract standardisation varies; effects within days for anxiety,No,Anxiety relief,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs are lacking; most evidence from general anxiety and insomnia populations.
Rhodiola Rosea,Rhodiola rosea; as Rhodiola; Golden root; Arctic root; SHR-5,Botanical,Some,"Multiple RCTs show stress adaptation, mental fatigue reduction, and burnout improvement. Adaptogenic mechanism. Perimenopause relevance for fatigue and stress resilience. SHR-5 is most-studied extract.",200,600,mg,Standardised to rosavins and salidrosides (3%:1% ratio); SHR-5 extract has most evidence; stimulating — take in morning; may interact with CYP3A4 substrates; effects within 3-5 days for acute fatigue.,Yes,Fatigue reduction,No,No,No,No,No,Yes,Low,Perimenopause-specific long-term RCTs are limited; optimal dose and duration not established.
Holy Basil,Ocimum tenuiflorum; Ocimum sanctum; as Holy Basil; Tulsi; Ocimum,Botanical,Limited,"Limited RCT evidence for stress, blood glucose, and anti-inflammatory effects. Traditional Ayurvedic adaptogen. Limited evidence in Western populations.",300,2000,mg,Standardisation of extracts varies widely; blood glucose lowering — caution in diabetics on medication; limited Western quality RCT data.,No,Stress adaptation,No,No,No,No,No,Yes,Low,Very limited independent Western RCT evidence for perimenopausal applications.
Ginkgo Biloba,Ginkgo biloba extract; EGb761; LI1370; as Ginkgo Biloba,Botanical,Strong,Multiple RCTs and meta-analyses show cognitive benefit in age-related cognitive decline and dementia. Some evidence for sexual dysfunction and anxiety. Antiplatelet effect. EGb761 is most-studied standardised extract.,120,240,mg,"EGb761 (24% flavonoids, 6% terpene lactones) is most evidence-based extract; strong anticoagulant/antiplatelet effect — avoid with warfarin, aspirin, clopidogrel; potential drug interactions with CYP substrates; stop 2 weeks before surgery.",Yes,Cognitive support,No,No,Yes,No,No,Unknown,Medium,Perimenopause-specific RCTs for cognitive fog are limited; anticoagulant interaction profile requires careful prescriber guidance.
Gotu Kola,Centella asiatica; as Gotu Kola; Indian pennywort; Brahmi (sometimes confused with Bacopa),Botanical,Some,"RCTs show benefit for venous insufficiency, wound healing, cognitive function, and anxiety. Some perimenopause cognitive and skin evidence. Anti-fibrotic and collagen-stimulating properties.",30,500,mg,Standardised to asiaticosides; separate from Brahmi (Bacopa monnieri) which is different plant; liver enzyme elevation reported at high doses — liver caution; take with food.,No,Cognitive support,No,No,No,Yes,No,Yes,Low,Perimenopause-specific RCTs are limited; hepatotoxicity risk at high doses needs monitoring.
Lion's Mane Mushroom,Hericium erinaceus; as Lion's Mane; yamabushitake; Lion's Mane extract,Botanical,Some,RCTs show cognitive benefits for mild cognitive impairment and anxiety/depression. Stimulates nerve growth factor (NGF). Perimenopause cognitive relevance. Evidence base growing post-2022.,250,3000,mg,Post-2022: new RCTs published supporting cognitive and mood benefits; standardised extracts (>30% beta-glucans) preferred; full-spectrum fruiting body vs mycelium have different active compound profiles; generally well tolerated; some mushroom allergy cases.,Yes,Cognitive support,No,No,No,No,No,Yes,Low,Post-2022: evidence base growing; perimenopause-specific long-term RCTs still needed.
Reishi Mushroom,Ganoderma lucidum; as Reishi; Lingzhi; Ganoderma,Botanical,Limited,"Limited RCT evidence for immune modulation, sleep, and fatigue. Some anti-androgenic activity relevant to PCOS. Liver toxicity reported at high doses. Well-studied preclinically but limited robust human RCTs.",1500,5000,mg,Triterpene and beta-glucan content varies widely between products; full-spectrum extract preferred; liver toxicity reported at high doses and with certain preparations — liver caution; anti-androgenic properties potentially relevant to PCOS.,No,Immune support,No,No,No,Yes,Yes,Unknown,Medium,Robust independent human RCTs for perimenopausal outcomes are absent; hepatotoxicity monitoring required.
St John's Wort,Hypericum perforatum; as St John's Wort; SJW; LI160; WS5570,Botanical,Strong,"Strong RCT evidence for mild to moderate depression comparable to SSRIs. Multiple RCTs in menopausal women for mood and vasomotor symptoms. Significant CYP3A4/P-gp drug interactions (reduces efficacy of contraceptives, antivirals, cyclosporine, warfarin).",300,900,mg,"Licensed herbal medicine in UK (MHRA THR); strong drug interactions via CYP3A4 induction — reduces oral contraceptive, antiretroviral, warfarin, cyclosporine, and many other drug levels significantly; DO NOT combine with SSRIs (serotonin syndrome); photosensitivity at high doses.",Yes,Depression/mood,Yes,No,No,No,No,Unknown,Low,Drug interaction profile is well characterised but patient awareness remains poor; combination with SSRIs is dangerous.
Lavender,Lavandula angustifolia; Silexan; as Lavender; lavender oil,Botanical,Some,"Silexan (80mg oral lavender oil) has multiple RCTs showing benefit for generalised anxiety disorder, sleep, and mixed anxiety/depression. MHRA licensed as Kalms Lavender. Perimenopause anxiety and sleep relevance.",80,160,mg,"Silexan (Kalms Lavender, Lasea) is MHRA-licensed anxiolytic in UK; 80mg/day dose used in RCTs; aromatotherapy evidence separate and weaker; do not use orally with other sedatives; anticoagulant interaction possible at high doses.",Yes,Anxiety relief,No,No,Possible,No,No,Yes,Low,Perimenopause-specific long-term RCTs beyond anxiety and sleep outcomes are lacking.
Lemon Balm,Melissa officinalis; as Lemon Balm; Melissa,Botanical,Some,"RCTs show anxiolytic and sleep benefits, often combined with valerian. Cognitive benefits in some small trials. Well tolerated. Antiviral (herpes simplex) topical evidence.",300,900,mg,Often combined with valerian for synergistic sleep benefit; may cause mild sedation — caution with sedative medications; effects within days for acute anxiety; well tolerated at studied doses.,No,Anxiety/sleep,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs are lacking; most evidence from general anxiety and sleep populations.
Hops,Humulus lupulus; as Hops; hop strobiles; 8-prenylnaringenin,Botanical,Some,"Some RCTs for menopausal symptoms and sleep, often combined with other botanicals. 8-prenylnaringenin (8-PN) is most potent known phytoestrogen. Oestrogenic activity significant. Often in hop-valerian combinations.",60,500,mg,8-prenylnaringenin is strongest known phytoestrogen — avoid in oestrogen-sensitive conditions; often combined with valerian and passionflower; sedative effects noted; caution in oestrogen-sensitive cancers.,Yes,Sleep/menopause,No,No,No,No,Yes,No,Medium,Long-term safety in oestrogen-sensitive populations and RCT evidence quality for standalone hops is limited.
Wild Yam,Dioscorea villosa; as Wild Yam; Mexican yam; Dioscorea extract,Botanical,Limited,Wild yam contains diosgenin which is a precursor to progesterone in laboratory synthesis but this conversion DOES NOT occur in the human body. RCT evidence for menopausal symptom relief is absent or negative. Widely marketed but evidence base poor.,100,1200,mg,Diosgenin in wild yam cannot be converted to progesterone in the body — marketing claims of 'natural progesterone' are misleading; no meaningful RCT evidence for menopause symptom relief; caution in oestrogen-sensitive conditions due to some oestrogenic activity.,Yes,None established,No,No,No,No,Yes,Unknown,Medium,Evidence for claimed hormonal benefits is essentially absent; widely marketed but poorly evidenced for perimenopause.
Fenugreek,Trigonella foenum-graecum; as Fenugreek; methi; Testofen; Furocyst,Botanical,Some,"RCTs show benefit for blood glucose, libido in women, and lactation support. Testosterone-modulating and oestrogenic properties. Testofen standardised extract has female sexual function RCT evidence.",300,600,mg,Oestrogenic and testosterone-modulating — avoid in oestrogen-sensitive conditions; may lower blood glucose — caution in diabetics; odour in sweat/urine is common harmless side effect; Testofen (600mg/day) has most female libido evidence.,Yes,Sexual function,No,No,No,No,Yes,Unknown,Low,Long-term safety and perimenopause-specific RCTs beyond libido are limited.
Tribulus Terrestris,Tribulus terrestris; as Tribulus; puncture vine; Tribulus extract,Botanical,Some,RCTs show benefit for female sexual dysfunction and premenopausal/perimenopausal women specifically. Does not significantly raise testosterone in human RCTs contrary to popular claims. Ovarium compositum data.,250,750,mg,Female sexual function evidence more convincing than testosterone-raising claims; standardised to saponins (protodioscin); may have mild oestrogenic activity — caution in oestrogen-sensitive conditions; most sexual function RCTs in women 40-55.,Yes,Sexual function,No,No,No,No,Possible,Unknown,Low,Standardisation of active compounds across products varies; long-term safety data limited.
Schisandra,Schisandra chinensis; as Schisandra; five-flavour berry; Wu Wei Zi,Botanical,Limited,"Limited but growing RCT evidence for liver protection, adaptogenic stress response, and some menopausal symptom relief. Traditional Chinese medicine ingredient.",100,1500,mg,Standardised to schisandrins and gomisins; liver-protective — ironically also liver caution at very high doses; limited Western clinical evidence; most studies from Chinese literature.,Yes,Adaptogenic support,No,No,No,Yes,No,Unknown,Low,Limited Western independent RCTs; standardisation and quality control of preparations vary widely.
Siberian Ginseng,Eleutherococcus senticosus; as Siberian Ginseng; Eleuthero; Eleutherokokk,Botanical,Some,"RCTs show adaptogenic benefits for stress, fatigue, and immune function. Distinct from Panax ginseng — different active compounds (eleutherosides not ginsenosides). Well tolerated.",400,1200,mg,Different plant from Panax ginseng; standardised to eleutherosides; generally well tolerated; mild hypertensive effect in some individuals — caution in hypertension; some evidence for menopausal fatigue.,No,Stress/fatigue,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs are limited; distinction from Panax ginseng evidence often conflated.
Panax Ginseng,Korean ginseng; Asian ginseng; Ginseng; as Panax Ginseng; G115,Botanical,Some,Multiple RCTs for cognitive function energy immune function and menopausal symptoms. G115 standardised extract has most evidence. Some evidence for female sexual function and hot flushes.,200,400,mg,G115 extract (4% ginsenosides) most evidence-based; stimulating - avoid taking late in day; may interact with warfarin and blood pressure medications; mild oestrogenic activity; avoid in oestrogen-sensitive conditions; effects within 8-12 weeks.,Yes,Energy/cognition,No,No,Possible,No,Possible,No,Low,Optimal dose duration and safety in oestrogen-sensitive perimenopausal women not established.
Licorice Root,Glycyrrhiza glabra; as Licorice Root; DGL; deglycyrrhizinated licorice; Glycyrrhiza uralensis,Botanical,Some,Standard licorice has significant oestrogenic and anti-androgenic activity. RCTs show hot flush reduction. DGL form has glycyrrhizin removed — reduced hormonal and blood pressure effects. High-dose licorice raises blood pressure and causes hypokalaemia.,150,600,mg,High-dose licorice with glycyrrhizin raises blood pressure and lowers potassium — significant risk; DGL (deglycyrrhizinated) is safer for GI applications; oestrogenic activity — avoid in hormone-sensitive conditions; upper tolerable limit for glycyrrhizin is 2mg/kg/day.,Yes,Hot flush reduction,No,No,No,No,Yes,No,Medium,Long-term cardiovascular safety in perimenopausal women with standard licorice not established; DGL lacks hot flush RCT evidence.
Turmeric/Curcumin,Curcuma longa; Curcumin; BCM-95; Meriva; Theracurmin; as Turmeric; as Curcumin,Botanical,Some,"Multiple small RCTs show anti-inflammatory, joint, cognitive, and mood benefits. Poor bioavailability of standard curcumin limits efficacy — enhanced forms (BCM-95, Meriva, Theracurmin) have 20-185x higher bioavailability. Perimenopause relevance for inflammation and mood.",500,2000,mg,"Standard curcumin has very poor bioavailability (<1%); always use enhanced bioavailability form (BCM-95, Meriva, Theracurmin, or with piperine); may interact with anticoagulants and chemotherapy at high doses; anti-platelet effects; liver safety at very high doses.",No,Anti-inflammatory,No,No,Yes,Yes,No,Yes,Low,Post-2022: several perimenopause-specific mood and cognitive RCTs published with enhanced forms; optimal form and dose not standardised.
Pycnogenol,French maritime pine bark extract; Pinus pinaster; as Pycnogenol; OPC extract,Botanical,Some,"Multiple RCTs specifically in perimenopausal women show reduction in hot flushes, sleep improvement, and cognitive function. Antioxidant and anti-inflammatory mechanism. MASCULA and other specific trials available.",50,200,mg,Standardised to OPCs; well tolerated; mild anticoagulant effect; pycnogenol has most perimenopause RCT data of any single proprietary extract; manufactured by Horphag Research.,Yes,Menopause symptom relief,No,No,Possible,No,No,Yes,Low,Long-term safety data beyond 12 months in perimenopausal women limited; comparison to standard HRT not established.
Grape Seed Extract,Proanthocyanidins; OPC; as Grape Seed Extract; Leucoselect; MegaNatural,Botanical,Some,"RCTs show cardiovascular, antioxidant, and blood pressure benefits. Some cognitive evidence. Commonly confused with pine bark OPCs. Standardised to proanthocyanidins.",100,400,mg,Standardised to proanthocyanidins (OPCs); mild anticoagulant effect; take with food; generally well tolerated; different from red wine resveratrol though both from grapes.,No,Antioxidant/cardiovascular,No,No,Possible,No,No,Yes,Low,Perimenopause-specific RCTs are limited compared to Pycnogenol.
Milk Thistle,Silybum marianum; as Milk Thistle; Silymarin; Legalon,Botanical,Strong,Strong evidence for liver protection in toxic liver injury and cirrhosis. Some evidence for fatty liver disease. EFSA and ESCOP monograph supported. Liver protective properties well established. Limited perimenopause-specific data but relevant for supplement liver safety.,140,420,mg,"Standardised to silymarin (70-80%); MHRA licensed products available in UK; generally very well tolerated; liver protective — important for women taking other hepatotoxic supplements (black cohosh, kava); minimal drug interactions.",No,Liver protection,No,No,No,No,No,Yes,Low,Perimenopause-specific outcomes beyond liver protection not studied in RCTs.
Bacopa Monnieri,Bacopa; Brahmi; as Bacopa Monnieri; CDRI08; Synapsa,Nootropic,Some,"Multiple RCTs show improvements in memory, attention, and cognitive processing speed. Effects accumulate over 8-12 weeks. Well-studied extract CDRI08 (Synapsa) has most evidence. Perimenopause cognitive fog relevance.",300,600,mg,Standardised to bacosides (20%); CDRI08 (Synapsa) is most evidence-based extract; effects take 8-12 weeks of consistent use; may cause GI upset — take with food; cholinergic mechanism may be relevant for cognitive fog.,Yes,Memory improvement,No,No,No,No,No,Yes,Low,Perimenopause-specific cognitive RCTs with standardised extracts are limited; optimal dose for age-related cognitive decline in women 40-55 not established.
Alpha-GPC,Alpha-glycerylphosphorylcholine; Choline alfoscerate; as Alpha-GPC; L-alpha-GPC,Nootropic,Some,RCTs show cognitive benefits in Alzheimer's disease and age-related cognitive decline. Acetylcholine precursor with high bioavailability. Some evidence for physical performance. Regulated as medicine in some EU countries.,400,1200,mg,Regulated as medicine (not supplement) in some EU countries — regulatory risk varies; 50% form requires double the dose of 99% form; generally well tolerated; supports acetylcholine synthesis important for memory.,No,Cognitive support,No,No,No,No,No,Yes,Medium,Perimenopause-specific cognitive RCTs are limited; regulatory status varies across EU jurisdictions.
Citicoline,CDP-choline; Cytidine 5-diphosphocholine; as Citicoline; as CDP-Choline; Cognizin,Nootropic,Some,"Multiple RCTs show cognitive benefits including memory, attention, and brain energy. Cognizin branded form has most evidence. Precursor to both phosphatidylcholine and acetylcholine. Well tolerated.",250,1000,mg,Cognizin is most-studied branded form; well tolerated; cognitive benefits seen in multiple populations including older adults; take in morning as may be activating; different mechanism from Alpha-GPC but both increase acetylcholine.,No,Cognitive support,No,No,No,No,No,Yes,Low,Perimenopause-specific cognitive decline RCTs are lacking.
Phosphatidylserine (Nootropic),PS; Sharp-PS; as Phosphatidylserine; soy PS; sunflower PS,Nootropic,Strong,"Multiple RCTs demonstrate memory, attention, and cognitive benefits. HPA axis regulation evidence. FDA qualified health claim for cognitive decline. Well tolerated.",100,400,mg,Soy or sunflower derived (bovine no longer used); EFSA health claim recognised; take with meals; most consistent evidence of any nootropic ingredient for memory in adults.,Yes,Memory/cognition,No,No,No,No,No,Yes,Low,Perimenopause-specific long-term trials are lacking; existing evidence mostly in cognitive impairment populations.
Vinpocetine,Ethyl apovincaminate; as Vinpocetine; cavinton,Nootropic,Limited,Limited RCT evidence for cerebral blood flow and cognitive function. Approved as prescription medicine in Hungary and some countries. Regulatory grey area in UK/EU as supplement.,5,30,mg,Regulatory status uncertain in UK/EU — may be classified as medicine rather than supplement; some evidence for cerebral blood flow; anti-platelet effects; generally well tolerated at studied doses.,No,Cognitive support,No,No,Yes,No,No,Unknown,High,Regulatory status in UK/EU is uncertain; limited perimenopause-specific evidence.
Huperzine A,as Huperzine A; Huperzia serrata extract,Nootropic,Limited,Acetylcholinesterase inhibitor; limited RCT evidence from Chinese trials for Alzheimer's and cognitive impairment. Mechanism similar to pharmaceutical cholinesterase inhibitors (donepezil). Thin evidence base for healthy adult use.,50,200,mcg,"Strong cholinesterase inhibitor — avoid with Alzheimer's medications (donepezil, rivastigmine); seizure risk at high doses; narrow therapeutic window; limited high-quality independent RCTs; regulatory caution advised.",No,Cognitive support,No,No,No,No,No,Unknown,High,Safety profile and drug interactions in perimenopausal women not established; limited independent high-quality RCTs.
Saffron,Crocus sativus; as Saffron; Affron; Safranal; Crocin,Botanical,Some,Multiple small RCTs show significant antidepressant effects comparable to low-dose SSRIs for mild to moderate depression. Some perimenopause-specific data for mood and sexual function. Affron branded extract has most evidence.,28,90,mg,Affron extract (3.5% lepticrosalide) has most perimenopause mood evidence; well tolerated; avoid in pregnancy (uterine stimulant); anti-platelet effects at high doses; sexual function evidence in SSRI-induced sexual dysfunction.,Yes,Mood/antidepressant,Possible,No,Possible,No,No,No,Low,Post-2022: growing perimenopause-specific mood and hot flush evidence from Affron trials; long-term safety beyond 12 weeks limited.
Spearmint,Mentha spicata; as Spearmint; spearmint tea extract,Botanical,Limited,Limited RCT evidence for anti-androgenic activity in PCOS (reducing free testosterone). Relevant for perimenopausal women with androgen excess symptoms (hirsutism). Spearmint tea studies primarily.,200,900,mg,Anti-androgenic through 5-alpha-reductase inhibition; most evidence from spearmint tea consumption (2 cups/day); standardised extract evidence limited; PCOS evidence most consistent.,No,Anti-androgen,No,No,No,No,Yes,Yes,Low,Perimenopausal androgen excess RCTs specifically are very limited.
Fennel,Foeniculum vulgare; as Fennel; Fennel seed extract,Botanical,Limited,Very limited RCT evidence for menopausal symptom relief and dysmenorrhoea. Phytoestrogenic activity documented. Traditional women's herb with limited modern clinical evidence.,100,480,mg,Phytoestrogenic — avoid in oestrogen-sensitive conditions; limited modern RCT quality; dysmenorrhoea evidence from some small trials.,Yes,Menopause symptoms,No,No,No,No,Yes,Unknown,Medium,Very limited independent RCT evidence; oestrogenic safety profile in hormone-sensitive women poorly characterised.
Flaxseed Lignans,Lignan; Secoisolariciresinol diglucoside; SDG; as Flaxseed Lignans; flaxseed extract,Botanical,Some,RCTs show modest hot flush reduction in postmenopausal women. Phytoestrogenic lignan activity via enterolignans. Cardiovascular and gut health evidence. Generally well tolerated.,360,3000,mg,"Converted to enterolignans (enterodiol, enterolactone) by gut bacteria — variable response depending on microbiome; whole flaxseed and lignan extract have different bioavailability; phytoestrogenic — caution in oestrogen-sensitive conditions.",Yes,Hot flush reduction,No,No,No,No,Yes,Yes,Low,Individual variation in lignan metabolism based on gut microbiome composition makes response unpredictable.
Moringa,Moringa oleifera; as Moringa; drumstick tree; Moringa leaf extract,Botanical,Limited,"Limited RCT evidence for blood glucose, anti-inflammatory, and nutritional supplementation in deficient populations. Growing interest for women's health but clinical evidence thin.",500,2000,mg,Nutritionally dense but clinical evidence thin; standardisation of extracts varies; blood glucose lowering — caution in diabetics; limited perimenopause-specific data.,No,Nutritional support,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs are essentially absent; mechanistic and nutritional claims outpace clinical evidence.
DHEA,Dehydroepiandrosterone; as DHEA; prasterone; Intrarosa,Hormone,Strong,"Multiple RCTs show DHEA supplementation increases testosterone and oestrogen, improves sexual function, bone density, and mood in perimenopausal and postmenopausal women. Prescription medicine in UK. Intrarosa is licensed vaginal DHEA. Oral DHEA regulated differently.",10,100,mg,"Licensed as prescription medicine in UK for GSM (Intrarosa, vaginal); oral DHEA is MHRA grey area; age and baseline DHEA level important for dosing; highly hormone-active — avoid in oestrogen/androgen-sensitive cancers; 25-50mg/day commonly used in research.",Yes,Sexual/hormonal health,No,No,No,No,Yes,No,High,Optimal oral dose for perimenopausal women without hormone-sensitive conditions; long-term cardiovascular safety not established.
7-Keto DHEA,7-Keto; 7-oxo-DHEA; as 7-Keto DHEA; 3-acetyl-7-oxo-DHEA,Hormone,Limited,Metabolite of DHEA that does not convert to sex hormones. Limited RCT evidence for weight management and immune function. Lower hormonal risk than DHEA. Limited perimenopause-specific data.,50,200,mg,Does not convert to oestrogen or testosterone — potentially safer profile than DHEA; limited human RCT evidence; weight management evidence from small trials; regulatory status varies.,No,Weight management,No,No,No,No,No,Unknown,Medium,Very limited independent RCT evidence; most studies industry-funded; perimenopause-specific outcomes not established.
Pregnenolone,as Pregnenolone; pregnenolone sulfate,Hormone,Limited,"Master steroid hormone precursor. Very limited human RCT evidence. Highly hormone-active as precursor to DHEA, progesterone, and corticosteroids. Regulatory concerns in UK.",10,100,mg,"Highly hormone-active — can convert to multiple sex hormones including oestrogen, progesterone, and testosterone; very limited human RCT evidence; regulatory status in UK uncertain; avoid in hormone-sensitive conditions and cancer.",No,Hormonal support,No,No,No,No,Yes,Unknown,High,Almost no reliable independent human RCT evidence; regulatory status and safety profile in UK poorly established.
Melatonin,as Melatonin; N-acetyl-5-methoxytryptamine; Circadin,Hormone,Strong,"Multiple RCTs and meta-analyses show melatonin effective for sleep onset, jet lag, and circadian rhythm disorders. Perimenopausal sleep disruption is a major indication. Circadin is licensed medicine in UK for >55 years. Low doses (0.5-1mg) may be equally effective as higher doses.",0.5,10,mg,Licensed as prescription medicine in UK above 1mg (Circadin); low doses (0.5-1mg) as effective as higher doses for sleep; exogenous melatonin may suppress endogenous production at high doses; take 30-60 minutes before desired sleep time; not recommended for under-18 without medical supervision.,Yes,Sleep onset,No,No,No,No,Yes,Unknown,Medium,Optimal dosing for perimenopausal sleep disruption specifically; long-term effects on endogenous melatonin production not established.
Lactobacillus acidophilus,L. acidophilus; as Lactobacillus acidophilus; NCFM; LA-5,Probiotic,Some,"RCTs support L. acidophilus for gut dysbiosis, vaginal health, and immune function. NCFM strain has most evidence for gut. LA-5 combined with Bifidobacteria widely studied. Some evidence for vaginal pH and infection prevention.",1000000000,50000000000,CFU,Strain specificity matters — benefits of one strain do not apply to all; refrigeration often required for viability; enteric coating improves survival through stomach acid; viability at time of consumption important (check CFU guarantee at expiry not manufacture).,No,Gut health,No,No,No,No,No,Yes,Low,Perimenopause-specific vaginal and gut microbiome RCTs are growing but underpowered.
Lactobacillus rhamnosus,L. rhamnosus; LGG; Lactobacillus rhamnosus GG; as Lactobacillus rhamnosus,Probiotic,Strong,LGG (GG strain) is one of the most studied probiotic strains globally. Strong evidence for prevention and treatment of antibiotic-associated diarrhoea. Some evidence for immune function and gut barrier integrity. Widely used clinically.,1000000000,20000000000,CFU,LGG (Culturelle) is most evidence-based strain; strain specificity critical; generally well tolerated; beneficial after antibiotic courses; effects are strain-specific — LGG evidence does not apply to all L. rhamnosus strains.,No,Gut health,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs with LGG for mood (gut-brain axis) and hormonal outcomes are limited.
Lactobacillus reuteri,L. reuteri; RC-14; DSM 17938; as Lactobacillus reuteri,Probiotic,Some,RC-14 strain (with L. rhamnosus GR-1) shows strong evidence for vaginal health and UTI prevention. DSM 17938 has infant colic evidence. RC-14 perimenopause relevance for vaginal microbiome.,1000000000,10000000000,CFU,Strain identity critical — RC-14 and DSM 17938 have completely different evidence bases; RC-14 combined with L. rhamnosus GR-1 for vaginal health is well-evidenced combination; refrigeration required.,Yes,Vaginal health,No,No,No,No,No,Yes,Low,Perimenopausal vaginal microbiome changes and probiotic intervention RCTs are an emerging but growing area.
Lactobacillus crispatus,L. crispatus; as Lactobacillus crispatus; LACTIN-V,Probiotic,Some,Dominant vaginal Lactobacillus species associated with healthy vaginal microbiome. LACTIN-V product has RCT evidence for BV prevention. Highly relevant for perimenopausal vaginal microbiome changes.,1000000000,10000000000,CFU,Natural dominant strain of healthy vaginal microbiome; colonisation challenging via oral route — may require vaginal delivery for local effect; LACTIN-V (vaginal capsule) is investigational product with RCT evidence for BV.,Yes,Vaginal microbiome,No,No,No,No,No,Yes,Low,Oral supplementation route efficacy for vaginal colonisation is uncertain; perimenopausal-specific RCTs are limited.
Lactobacillus gasseri,L. gasseri; SBT2055; as Lactobacillus gasseri,Probiotic,Some,SBT2055 strain has RCT evidence for abdominal fat reduction and weight management in overweight individuals. Vaginal health applications also studied. Perimenopause metabolic relevance.,1000000000,10000000000,CFU,SBT2055 strain most studied for metabolic outcomes; strain specificity critical; effects modest in RCTs; perimenopausal metabolic change relevance,Yes,Weight/metabolic,No,No,No,No,No,Yes,Low,Perimenopause-specific metabolic RCTs are limited; weight reduction effects modest.
Bifidobacterium longum,B. longum; BB536; as Bifidobacterium longum; NCIMBi 41676,Probiotic,Some,"RCTs show immune, allergy, and gut health benefits. BB536 strain has evidence for respiratory infections and allergy. Gut-brain axis evidence emerging. B. longum declines with age making supplementation more relevant in 40+ women.",1000000000,20000000000,CFU,BB536 is most-studied strain; Bifidobacterium species decline naturally with age — supplementation increasingly relevant in perimenopausal age group; strain specificity important.,Yes,Gut/immune health,No,No,No,No,No,Yes,Low,Perimenopausal gut-brain axis and mood outcome RCTs specifically are lacking.
Bifidobacterium breve,B. breve; BR03; as Bifidobacterium breve; Bif195,Probiotic,Limited,Limited RCT evidence for gut health and immune function. Some infant formula evidence. Limited standalone adult evidence for perimenopause applications.,1000000000,10000000000,CFU,Strain specificity critical; limited adult RCT evidence; often included in multi-strain probiotic blends.,No,Gut health,No,No,No,No,No,Yes,Low,Adult and perimenopause-specific standalone RCTs are very limited.
Bifidobacterium lactis,B. lactis; BB-12; as Bifidobacterium lactis; HN019,Probiotic,Strong,"BB-12 has strong RCT evidence for gut transit, immune function, and antibiotic-associated diarrhoea. HN019 has strong evidence for gut transit time. One of most-studied probiotic strains globally.",1000000000,25000000000,CFU,"BB-12 and HN019 are distinct strains with different evidence profiles; BB-12 has strongest commercial evidence base; generally very well tolerated; CFU dose important — ensure adequate dose at expiry date, not manufacture.",No,Gut transit/immune,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs for hormonal and vaginal microbiome outcomes are limited.
Saccharomyces boulardii,S. boulardii; as Saccharomyces boulardii; CNCM I-745; Florastor,Probiotic,Strong,Strong RCT and meta-analysis evidence for antibiotic-associated diarrhoea and C. diff prevention. Well tolerated. Yeast-based — not affected by antibiotics (unlike bacterial probiotics). Unique profile.,250,1000,mg,"Yeast not bacteria — not affected by antibiotic use, making it ideal during antibiotic courses; well tolerated; caution in immunocompromised patients; stored at room temperature unlike many bacterial probiotics.",No,Antibiotic diarrhoea,No,No,No,No,No,Yes,Low,Perimenopause-specific applications beyond gut health not studied in RCTs.
Inulin,Chicory inulin; FOS; as Inulin; prebiotic inulin; chicory root extract,Probiotic,Some,"RCTs show inulin improves gut microbiome composition (bifidobacterium growth), calcium absorption, and bowel function. Prebiotic activity well established. Some evidence for glucose and lipid metabolism.",2500,15000,mg,Start low and increase gradually to avoid gas and bloating; effective dose 5-10g/day; inulin and FOS are bifidogenic prebiotics; chicory root is main commercial source; synergistic with probiotic supplementation.,No,Gut prebiotic,No,No,No,No,No,Yes,Low,Perimenopause-specific microbiome and hormonal outcome RCTs are limited.
FOS,Fructooligosaccharides; FOS; as FOS; as Fructooligosaccharides; short-chain FOS; scFOS,Probiotic,Some,Similar evidence to inulin for gut microbiome and prebiotic activity. Some evidence for mineral absorption enhancement. Bifidogenic prebiotic effect well established.,2000,10000,mg,Similar profile to inulin; short-chain FOS (scFOS) may be better tolerated at higher doses than long-chain inulin; gas and bloating at higher doses common during adaptation.,No,Gut prebiotic,No,No,No,No,No,Yes,Low,Optimal dose and type for perimenopausal microbiome and hormonal metabolism are not established.
Beta-Glucan,"Oat beta-glucan; Barley beta-glucan; as Beta-Glucan; 1,3/1,4-beta-glucan",Probiotic,Strong,Strong EFSA-approved health claim for cholesterol reduction and blood glucose management. Excellent cardiovascular evidence. Immune modulation evidence from oat and yeast beta-glucans. Perimenopause cardiovascular relevance.,2000,6000,mg,"EFSA approved health claim at 3g/day for cholesterol reduction; oat and barley beta-glucans most evidence-based; yeast-derived beta-glucans (1,3/1,6) have different immune modulation evidence; soluble fibre mechanism; take with water or food.",Yes,Cholesterol reduction,No,No,No,No,No,Yes,Low,Perimenopause-specific cardiovascular outcome RCTs using beta-glucan supplementation are limited.
Psyllium Husk,Plantago ovata husk; as Psyllium Husk; Metamucil; isabgol,Probiotic,Strong,"Strong evidence for cholesterol reduction, bowel function, and glycaemic management. EFSA health claim approved. Well tolerated soluble fibre. Also classified as bulk laxative.",3500,30000,mg,Take with large amounts of water to prevent oesophageal obstruction; can interfere with absorption of medications — take separately from other medications/supplements by 2 hours; EFSA health claim for cholesterol at 7g/day.,No,Cholesterol/bowel,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs for combined gut and cardiovascular outcomes are limited.
Microcrystalline Cellulose,MCC; as Microcrystalline Cellulose; E460; Avicel,Excipient,None,Inert excipient derived from plant cellulose. No pharmacological activity. Used as tablet binder and filler. GRAS status. No health concerns at typical supplement use levels.,0,0,mg,No dose considerations as pharmacologically inactive excipient; GRAS (Generally Recognised As Safe); EU food additive E460.,No,None,No,No,No,No,No,Yes,Low,Not applicable — excipient with no therapeutic activity.
Magnesium Stearate,Magnesium stearate; as Magnesium Stearate; stearic acid,Excipient,None,Inert lubricant excipient. Claims that it impairs nutrient absorption (biofilm theory) are not supported by evidence. Used at very low levels in supplements (<2%). GRAS status.,0,0,mg,Used at <2% in supplements; no evidence of clinically significant absorption interference at typical use levels; anti-caking and flow agent in powder processing.,No,None,No,No,No,No,No,Yes,Low,Not applicable — excipient with no therapeutic activity; negative claims about absorption interference are not evidence-based.
Silicon Dioxide,Silica; as Silicon Dioxide; E551; amorphous silica,Excipient,None,Anti-caking agent excipient. Inert at supplement levels. Nanoparticle silicon dioxide is subject to growing regulatory scrutiny. EFSA reviewed safety.,0,0,mg,Used as anti-caking agent at very low levels; EFSA has reviewed nano-SiO2 safety; conventional amorphous silica considered safe at supplement use levels.,No,None,No,No,No,No,No,Yes,Low,Nanoparticle silicon dioxide safety under ongoing regulatory review; conventional form considered safe.
HPMC,Hydroxypropyl methylcellulose; as HPMC; hypromellose; Vcaps,Excipient,None,Plant-derived capsule material and coating agent. Suitable for vegetarians and vegans. Inert and well tolerated. GRAS status.,0,0,mg,Preferred capsule material for vegetarian/vegan formulations; HPMC capsules can slow release — may affect bioavailability of enclosed ingredients in some formulations.,No,None,No,No,No,No,No,Yes,Low,Not applicable — inert excipient.
Hydroxypropyl Cellulose,HPC; as Hydroxypropyl Cellulose; E463,Excipient,None,Tablet binding and film coating agent. Inert. GRAS status. No pharmacological activity.,0,0,mg,Inert excipient; used as binder in tablet manufacture and film coating; GRAS.,No,None,No,No,No,No,No,Yes,Low,Not applicable — inert excipient.
Gelatin,Bovine gelatin; Porcine gelatin; as Gelatin; hard shell capsule,Excipient,None,"Animal-derived capsule material. Not suitable for vegetarians, vegans, or halal/kosher unless certified. No pharmacological activity. Well tolerated.",0,0,mg,Not suitable for vegetarians or vegans; porcine gelatin not suitable for Muslim or Jewish consumers — check certification; conventional hard-shell capsule material.,No,None,No,No,No,No,No,Yes,Low,Not applicable — excipient; consumer labelling considerations important.
Stearic Acid,as Stearic Acid; octadecanoic acid,Excipient,None,Tablet lubricant. Inert at supplement use levels. Derived from animal or vegetable sources. No pharmacological activity.,0,0,mg,Check vegetable vs animal source for vegan suitability; used at very low levels as tablet lubricant.,No,None,No,No,No,No,No,Yes,Low,Not applicable — excipient.
Titanium Dioxide,as Titanium Dioxide; E171; CI 77891,Excipient,None,White coating/colouring agent. EFSA banned E171 in food in 2022 due to genotoxicity concerns. Not permitted in food in UK (post-Brexit regulations still under review). Regulatory risk HIGH.,0,0,mg,Post-2022: EFSA banned E171 in EU food in 2022 due to inability to rule out genotoxicity; UK Food Standards Agency reviewing; should be avoided in new supplement formulations — significant regulatory and consumer risk.,No,None,No,No,No,No,No,Unknown,High,Post-2022: EU food ban implemented; UK regulatory status under review — HIGH risk for inclusion in new formulations.
Maltodextrin,as Maltodextrin; corn maltodextrin; modified starch,Excipient,None,Starch-derived carrier and bulking agent. High glycaemic index. GRAS status. Common in powder formulations as carrier. No pharmacological activity.,0,0,mg,High glycaemic index - relevant for diabetic consumers; derived from corn rice or wheat - coeliac risk if wheat-derived; commonly used as spray-drying carrier for powdered extracts.,No,None,No,No,No,No,No,Yes,Low,Glycaemic concerns for diabetic perimenopausal consumers; wheat-derived versions carry coeliac risk.
Carrageenan,as Carrageenan; E407; Irish moss extract,Excipient,None,Emulsifier and thickener derived from red seaweed. Subject to ongoing regulatory debate — some animal studies raise gut inflammation concerns. IARC limited carcinogenicity classification for degraded form. Food-grade carrageenan considered safe by EFSA.,0,0,mg,EFSA considers food-grade carrageenan safe; degraded carrageenan (poligeenan) is not permitted in food; some consumer concern exists; avoidance in IBD patients may be prudent.,No,None,No,No,No,No,No,Yes,Low,Ongoing debate about gut inflammation effects; precautionary avoidance may be appropriate for gut health-focused supplements.
Shellac,as Shellac; E904; lac resin,Excipient,None,Natural resin from lac insects; used as enteric or delayed-release tablet coating. Not suitable for vegans. GRAS and EU approved. No pharmacological activity.,0,0,mg,Not suitable for vegans as derived from insects; used for enteric coating and extended release; may cause contact allergy in rare cases.,No,None,No,No,No,No,No,Yes,Low,Not applicable — excipient; vegan labelling considerations important.
Talc,Magnesium silicate; as Talc; E553b,Excipient,None,Glidant and anti-caking agent. EFSA reviewed safety — approved for food use. Concerns about asbestos contamination in cosmetic talc but pharmaceutical/food grade is tested and regulated.,0,0,mg,Pharmaceutical-grade talc is tested for asbestos contamination and is regulated; cosmetic talc concerns do not directly apply to supplement-grade material; used at very low levels.,No,None,No,No,No,No,No,Yes,Low,Consumer perception concerns despite regulatory approval; asbestos testing certification important for quality assurance.
Vitamin E Tocotrienol,Delta-tocotrienol; Gamma-tocotrienol; Tocotrienol complex; as Tocotrienol; DeltaGold; EVNol,Vitamin,Some,"RCTs show cardiovascular, bone, and anti-cancer properties. May be more potent antioxidants than tocopherols. Some evidence for hot flush reduction. Less studied than tocopherols.",50,200,mg,Palm-derived (EVNol) is most common commercial source; annatto-derived (DeltaGold) provides delta-tocotrienols specifically; fat-soluble — take with food; may interfere with alpha-tocopherol absorption if co-supplemented at high doses.,Yes,Cardiovascular/bone,No,No,Yes,No,No,Yes,Low,Perimenopause-specific long-term RCTs for bone and cardiovascular outcomes are limited.
Quercetin,Quercetin; Quercetin dihydrate; as Quercetin; EMIQ; isoquercetin,Botanical,Some,"RCTs show anti-inflammatory, antiviral (COVID-19 studies), cardiovascular, and allergy benefits. Poor bioavailability of standard quercetin — EMIQ and isoquercetin forms have enhanced bioavailability. Some evidence for bone health.",250,1000,mg,"Standard quercetin has very poor oral bioavailability; EMIQ (enzymatically modified isoquercitrin) and isoquercetin have superior absorption; may interact with some drug transporters (P-gp, BCRP); generally well tolerated.",No,Anti-inflammatory,No,No,Possible,No,No,Yes,Low,Perimenopause-specific RCTs and optimal bioavailable form not established.
Apigenin,as Apigenin; chamomile apigenin; apigenin 7-glucoside,Botanical,Limited,Limited RCT evidence; potential anti-oestrogenic and anti-inflammatory effects. Sleep research interest (binds GABA-A receptors). Present in chamomile. Most evidence preclinical.,10,50,mg,Limited human clinical data; potential interaction with oestrogen-sensitive conditions; research at early stage; found in chamomile tea and various plant foods.,No,Sleep/anti-inflammatory,No,No,No,No,Yes,Unknown,Low,Almost no human RCT evidence; preclinical data cannot be extrapolated to clinical dosing.
Chamomile,Matricaria chamomilla; as Chamomile; German chamomile; Chamomile extract,Botanical,Some,RCTs show mild anxiolytic and sleep benefits. Some evidence for generalised anxiety disorder. Generally very well tolerated. Ragweed allergy cross-reactivity possible.,220,1100,mg,Avoid in ragweed/composite plant allergy; may mildly potentiate sedative effects; generally very well tolerated; apigenin is likely active component.,No,Anxiety/sleep,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs are lacking; most evidence from general anxiety populations.
Ashwagandha Sensoril,Withania somnifera Sensoril; as Ashwagandha Sensoril; 10% withanolides,Botanical,Some,"Sensoril (Natreon) has specific RCTs for stress, cognitive function, and sleep at lower doses than KSM-66. Higher withanolide content. Both root and leaf extract used.",125,250,mg,Higher withanolide content than KSM-66; root and leaf extract blend; specific Sensoril RCTs differ from KSM-66 evidence — cannot be considered interchangeable; 125-250mg dosing versus 300-600mg for KSM-66.,Yes,Stress/sleep,No,Yes,No,No,Yes,No,Low,Direct comparison RCTs of Sensoril vs KSM-66 for perimenopausal outcomes lacking.
Sulforaphane,Broccoli glucosinolates; SGS; Brassica oleracea extract; as Sulforaphane,Botanical,Some,"RCTs show antioxidant, anti-inflammatory, and hormonal metabolism benefits (oestrogen detoxification via NRF2 pathway). Some evidence for menopausal symptom reduction and oestrogen metabolism. Bioavailability varies with food processing.",10,50,mg,Myrosinase enzyme needed for sulforaphane formation from glucoraphanin — co-supplementation with myrosinase or mustard powder improves yield; broccoli sprouts have higher glucoraphanin than mature broccoli; highly relevant for oestrogen metabolism and DIM pathway.,Yes,Oestrogen metabolism,No,No,No,No,Yes,Yes,Low,Perimenopause-specific oestrogen detoxification RCTs and optimal dose not well established.
DIM,"Diindolylmethane; 3,3'-Diindolylmethane; as DIM; Brassica indole",Botanical,Some,"Some RCTs for oestrogen metabolism, promoting 2-OH oestrogen metabolites over 16-OH. Evidence for breast cancer risk reduction and hormonal balance. Highly relevant to perimenopause oestrogen metabolism.",100,300,mg,Promotes beneficial oestrogen metabolite pathway (2-OHE1 vs 16-OHE1); absorption improved with microencapsulation (BioResponse DIM); may cause harmless darkening of urine; oestrogen-active — caution in oestrogen-sensitive conditions; may interact with CYP1A2 substrates.,Yes,Oestrogen metabolism,No,No,No,No,Yes,Unknown,Medium,Long-term perimenopause safety and impact on oestrogen-sensitive tissue not established.
I3C,Indole-3-carbinol; as I3C; as Indole-3-Carbinol,Botanical,Limited,Precursor to DIM; less stable than DIM in gastric conditions. Some evidence for oestrogen metabolism and cervical health. Less reliable than DIM due to pH-dependent conversion.,200,800,mg,Converts to DIM and other compounds in stomach; DIM may be preferred for more predictable pharmacokinetics; cervical dysplasia RCT evidence; oestrogen-active; caution in oestrogen-sensitive conditions.,Yes,Oestrogen metabolism,No,No,No,Yes,Yes,Unknown,Medium,DIM may be more pharmacokinetically reliable; perimenopause-specific long-term safety unclear.
Rhodiola crenulata,Rhodiola; Hong Jing Tian; as Rhodiola crenulata,Botanical,Limited,Different species from R. rosea with different active compound profile. Limited RCT evidence. Often mislabelled or substituted for R. rosea in commercial products.,200,600,mg,Distinct from Rhodiola rosea; standardised to salidrosides rather than rosavins/salidroside combination; limited independent RCT evidence vs R. rosea; quality control and species authentication important.,No,Adaptogenic support,No,No,No,No,No,Yes,Low,Species distinction from R. rosea not always maintained in commercial products; independent RCTs very limited.
Astragalus,Astragalus membranaceus; as Astragalus; Huang Qi; TA-65,Botanical,Limited,Limited RCT evidence for immune function and telomere extension (TA-65 proprietary extract). Anti-ageing claims not well supported by human trial evidence. Immune modulation in oncology settings studied.,250,500,mg,TA-65 is proprietary cycloastragenol extract with telomerase activation claims — limited robust independent RCT evidence; standard astragalus has better immune evidence; may interact with immunosuppressant medications.,No,Immune support,No,No,No,No,No,Yes,Low,Anti-ageing and telomere claims significantly outpace robust independent RCT evidence.
Cinnamon Extract,Cinnamomum verum; Cinnamomum cassia; as Cinnamon Extract; ceylon cinnamon; cassia cinnamon,Botanical,Some,RCTs show modest blood glucose lowering and insulin sensitising effects. Ceylon cinnamon preferred over cassia due to lower coumarin content. Some PCOS evidence. Perimenopause metabolic relevance.,1000,6000,mg,Ceylon cinnamon has very low coumarin; cassia cinnamon has high coumarin — hepatotoxic at high doses; cassia should not be used at high supplemental doses long-term; modest evidence for glycaemic management.,No,Blood glucose control,No,No,No,Yes,No,Yes,Medium,Long-term perimenopause metabolic RCTs and safe upper dose for cassia form not established.
Olive Leaf Extract,Oleuropein; Olive leaf polyphenols; as Olive Leaf Extract; Olivenol; EFLA943,Botanical,Some,"RCTs show blood pressure lowering, antioxidant, and anti-inflammatory benefits. EFLA943 standardised extract has most evidence for cardiovascular outcomes. Mediterranean diet relevance.",500,1000,mg,Standardised to oleuropein; EFLA943 extract has blood pressure RCT evidence; generally well tolerated; antihypertensive effect — additive with blood pressure medication.,No,Blood pressure,No,No,No,No,No,Yes,Low,Perimenopause-specific cardiovascular RCTs are limited; blood pressure interaction with antihypertensive medication management needed.
Elderberry,Sambucus nigra; as Elderberry; Sambucol; BerryPharma,Botanical,Some,RCTs show Sambucol elderberry extract reduces severity and duration of cold and flu symptoms. Immune stimulation mechanism. Well tolerated. Most evidence from cold/flu intervention studies.,150,900,mg,Sambucol is most-studied standardised extract; raw elderberries contain toxic compounds — must be cooked or extracted; well tolerated at supplement doses; immune stimulation — theoretical caution in autoimmune conditions.,No,Immune support,No,No,No,No,No,Yes,Low,Perimenopause-specific immune and hormonal outcome RCTs are absent.
Echinacea,Echinacea purpurea; Echinacea angustifolia; as Echinacea; coneflower,Botanical,Some,Multiple RCTs show modest reduction in cold incidence and duration. Evidence for immune activation. Purpurea species best studied. Well tolerated short-term. Not recommended in autoimmune conditions.,900,4000,mg,"Echinacea purpurea has most evidence; avoid in autoimmune conditions (MS, SLE, RA); member of daisy family — ragweed allergy cross-reactivity; short courses (max 8 weeks) conventionally recommended.",No,Immune support,No,No,No,No,No,Yes,Low,Long-term continuous use safety and perimenopause-specific immune outcome RCTs are lacking.
Vitamin C Buffered,Sodium ascorbate; Calcium ascorbate; Ester-C; as Buffered Vitamin C,Vitamin,Some,Better tolerated by sensitive stomachs than ascorbic acid. Comparable bioavailability to standard ascorbic acid. Ester-C (calcium ascorbate with metabolites) claims superior bioavailability — evidence limited.,500,2000,mg,Preferred for individuals who experience GI discomfort with ascorbic acid; sodium ascorbate contributes sodium to diet — relevant for low-sodium diets; Ester-C bioavailability advantage over regular ascorbate not convincingly demonstrated.,No,Immune function,No,Possible,No,No,No,Yes,Low,Clinical superiority of buffered/Ester-C forms over standard ascorbic acid not established in head-to-head RCTs.
Choline,Choline bitartrate; Choline chloride; as Choline; CDP-Choline precursor,Other,Some,"Essential nutrient for liver function, brain development, and methylation. Many women are deficient. RCTs show benefits for cognitive function and liver health. AI established but not formally listed as UK RNI.",250,1000,mg,"UK does not have a formal RNI for choline; AI is 550mg/day for men, 425mg for women; choline bitartrate most common supplement form; fishy odour side effect at high doses; component of methylation cycle alongside folate and B12.",No,Liver/cognitive health,No,No,No,No,No,Yes,Low,Choline requirements during perimenopause transition (reduced oestrogen affects hepatic choline synthesis) not well established.
Inositol,Myo-inositol; D-chiro-inositol; as Inositol; as Myo-Inositol; Ovosit,Other,Some,Multiple RCTs demonstrate myo-inositol improves insulin sensitivity and ovarian function in PCOS. Some evidence for metabolic syndrome and anxiety (as phosphoinositol). Relevant to perimenopausal insulin resistance.,2000,4000,mg,Myo-inositol:D-chiro-inositol at 40:1 ratio mirrors physiological ratio in many PCOS RCTs; anxiety evidence at higher doses (18g/day); well tolerated; not the same as inositol hexaniacinate (different compound); relevant for perimenopausal metabolic change.,Yes,Insulin sensitivity,No,No,No,No,No,Yes,Low,Perimenopause-specific metabolic syndrome and insulin resistance RCTs are limited.
Glucosamine Sulfate,as Glucosamine Sulfate; glucosamine HCl; DONA; N-acetylglucosamine,Other,Strong,Multiple RCTs and a Cochrane review show glucosamine sulfate reduces knee OA pain and may slow cartilage degradation. DONA (1500mg/day crystalline glucosamine sulfate) has strongest evidence. Joint pain is common perimenopause symptom.,1500,1500,mg,DONA crystalline glucosamine sulfate (Rottapharm/Madaus) has most evidence at exactly 1500mg/day; glucosamine HCl has less RCT support; sulfate form preferred; may slightly affect blood glucose — caution in diabetes; derived from shellfish.,Yes,Joint pain relief,No,No,No,No,No,Yes,Low,Long-term perimenopause-specific joint health RCTs not available; most OA evidence from general adult populations.
Chondroitin Sulfate,as Chondroitin Sulfate; chondroitin; bovine chondroitin,Other,Some,"RCTs show modest joint pain and function benefits in OA, particularly when combined with glucosamine. Evidence for standalone chondroitin is less consistent. Perimenopause joint health relevance.",800,1200,mg,Usually combined with glucosamine; bovine and marine-derived chondroitin available; quality and standardisation varies widely between products; shark-derived versions face sustainability concerns.,Yes,Joint health,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs and comparison of chondroitin sources are lacking.
MSM,Methylsulfonylmethane; as MSM; dimethyl sulfone; DMSO2,Other,Some,"RCTs show anti-inflammatory and joint pain benefits, particularly in OA and exercise-induced muscle soreness. Often combined with glucosamine/chondroitin. Well tolerated.",1000,6000,mg,Generally well tolerated; may have anti-inflammatory additive effect with glucosamine and chondroitin; derived from DMSO chemistry — sulphur-containing compound.,Yes,Joint pain relief,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs are limited; combination with glucosamine/chondroitin vs standalone not well established.
Spirulina,Arthrospira platensis; as Spirulina; blue-green algae; Spirulina maxima,Other,Some,"RCTs show antioxidant, anti-inflammatory, blood glucose, and lipid management benefits. High protein content and micronutrient density. Heavy metal contamination risk with low-quality sources.",1000,8000,mg,"Heavy metal (lead, mercury, arsenic) contamination risk with non-certified sources — quality certification critical; may cause nausea at high doses; contains phenylalanine — avoid in phenylketonuria; some thyroid iodine relevance.",No,Antioxidant/nutrition,No,Yes,No,No,No,Yes,Medium,Post-2022: quality and contamination concerns highlighted; perimenopause-specific RCTs are absent.
Chlorella,Chlorella vulgaris; as Chlorella; green algae; Chlorella pyrenoidosa,Other,Limited,"Limited RCT evidence for detoxification, cholesterol, and nutritional supplementation. Heavy metal binding properties studied. Limited perimenopause-specific data.",1200,5000,mg,Heavy metal contamination risk — quality certification important; may interfere with warfarin (vitamin K content); gradually introduce to prevent GI upset; contains iodine — relevant for thyroid.,No,Detoxification/nutrition,No,Yes,No,No,No,Yes,Medium,Independent high-quality RCTs for perimenopausal applications are essentially absent.
Activated Charcoal,as Activated Charcoal; activated carbon,Other,None,No RCT evidence for detoxification in healthy individuals. Used medically for acute poisoning. Significantly interferes with absorption of all supplements and medications if taken simultaneously. Should not be used as supplement.,0,0,mg,AVOID co-administration with any supplement or medication — activated charcoal absorbs virtually all oral compounds non-selectively; no evidence for detoxification in healthy people; may cause constipation; interferes with nutrient absorption.,No,None,No,Yes,No,No,No,Unknown,High,No credible evidence base for wellness detoxification claims; significant risk of supplement/medication interference.
Ubiquinone (High Dose),CoQ10 100mg+; as High-dose CoQ10; Ubidecarenone 100mg,Performance,Some,"At doses above 100mg, absorption efficiency decreases. Some specific clinical applications (migraine prevention, Parkinson's, heart failure) use 300-1200mg. Standard perimenopause supplementation needs are typically met at 100-200mg.",100,400,mg,Fat-soluble — take with fatty meal; divided doses (morning and lunchtime) preferred above 200mg; choose solubilised or nano-emulsion forms for superior absorption at higher doses.,Yes,Mitochondrial support,No,No,No,No,No,Yes,Low,Optimal dose range specifically for perimenopausal energy and cardiovascular outcomes not established.
Nattokinase,as Nattokinase; subtilisin NAT; NSK-SD,Other,Some,Limited RCTs show fibrinolytic and blood pressure lowering effects. Significant anticoagulant activity. Derived from fermented soy (natto). Perimenopause cardiovascular relevance but significant drug interaction concern.,100,200,mg,"Significant anticoagulant/fibrinolytic activity — CONTRAINDICATED with warfarin, aspirin, clopidogrel and other anticoagulants; stop 2 weeks before surgery; not suitable with HRT-related cardiovascular monitoring without medical oversight.",No,Cardiovascular support,No,No,Yes,No,No,Unknown,Medium,Anticoagulant interaction profile in perimenopausal women not well characterised; small RCT base.
Serrapeptase,as Serrapeptase; serralysin; Serratia peptidase,Other,Limited,Limited and inconsistent RCT evidence for anti-inflammatory and pain relief applications. Derived from Serratia bacteria. Anticoagulant properties. Evidence base weak compared to NSAIDs.,10,60,mg,Enteric coating required for oral bioavailability; anti-platelet/anticoagulant effects — caution with blood thinners; limited robust RCT evidence; take on empty stomach.,No,Anti-inflammatory,No,No,Yes,No,No,Unknown,Medium,Evidence base is thin and inconsistent; perimenopause-specific applications not studied.
Grapefruit Seed Extract,GSE; Citrus paradisi seed extract; as Grapefruit Seed Extract,Other,Limited,Antimicrobial properties primarily studied in vitro. Oral RCT evidence for systemic benefits limited. Significant CYP3A4 inhibition — major drug interaction risk.,100,500,mg,"SIGNIFICANT DRUG INTERACTION: inhibits CYP3A4 — can dramatically increase blood levels of statins, CCBs, immunosuppressants, benzodiazepines and many other medications; avoid with multiple medications; antimicrobial evidence primarily in vitro.",No,Antimicrobial,No,No,No,No,No,Yes,High,CYP3A4 drug interaction profile makes this unsuitable for combination products without prescriber oversight.
Colostrum,Bovine colostrum; as Colostrum; first milk,Other,Some,"RCTs show immune modulation, gut integrity, and exercise recovery benefits. Contains IgG antibodies, growth factors, and lactoferrin. Some GI health evidence. Not suitable for vegans.",500,10000,mg,Bovine-derived — not suitable for vegans or those with milk protein allergy; IgA and IgG content varies between products; generally well tolerated; some evidence for gut permeability.,No,Immune/gut support,No,No,No,No,No,Yes,Low,Perimenopause-specific immune and hormonal outcome RCTs are absent.
Lactoferrin,as Lactoferrin; bovine lactoferrin; apolactoferrin,Other,Some,"RCTs show iron absorption enhancement, antimicrobial, and immune benefits. Iron-binding glycoprotein from milk. Some evidence for gut health and bone density in postmenopausal women.",100,300,mg,Bovine-derived — not suitable for vegans; iron-binding — take separately from iron supplements; well tolerated; apolactoferrin (iron-free form) and lactoferrin have different properties.,Yes,Iron absorption/immune,No,No,No,No,No,Yes,Low,Perimenopause-specific bone and iron absorption RCTs are limited.
Ginger Root,Zingiber officinale; as Ginger Root; ginger extract; gingerol,Botanical,Some,"Multiple RCTs for nausea, anti-inflammatory effects, and blood glucose management. Some evidence for joint pain. Antiplatelet activity at high doses. Generally very well tolerated.",250,2000,mg,Anticoagulant/antiplatelet at high doses — caution with warfarin; take with food to reduce GI irritation; generally well tolerated at dietary levels; standardised to gingerols and shogaols.,No,Anti-nausea,No,No,Possible,No,No,Yes,Low,Perimenopause-specific anti-inflammatory and metabolic outcome RCTs are limited.
Cayenne/Capsaicin,Capsicum annuum; Capsaicin; as Cayenne; TRPV1 agonist,Botanical,Limited,"Limited RCT evidence for metabolic rate, satiety, and topical pain. Oral capsaicin supplement evidence thin. Thermogenic effects modest in RCTs.",2,135,mg,High doses cause GI irritation; topical forms have much stronger evidence than oral for pain; thermogenic evidence modest and transient; generally well tolerated at supplement doses.,No,Metabolic support,No,No,No,No,No,Yes,Low,Perimenopause-specific metabolic RCTs for oral capsaicin supplementation are absent.
Coenzyme Q10 with PQQ,CoQ10 + PQQ combination; as CoQ10 PQQ complex,Performance,Limited,Combination products lack independent RCT evidence. Each ingredient has separate evidence bases that may be synergistic but human combination RCTs are minimal.,0,0,mg,Evaluate each component separately; no meaningful synergy-specific human RCT evidence; combination products driven by theoretical mechanism not clinical trial evidence.,No,Mitochondrial support,No,No,No,No,No,Yes,Low,No robust combination RCT evidence; theoretical synergy not validated in human trials.
Zinc Carnosine,Polaprezinc; L-carnosine zinc chelate; as Zinc Carnosine,Other,Some,"RCTs show benefit for gut mucosal repair, H. pylori eradication adjunct, and GI integrity. Different from zinc and carnosine separately — unique chelated compound. Perimenopause GI health relevance.",37,150,mg,Unique chelated compound; distinct from separate zinc and carnosine supplementation; licensed as medicine in Japan; GI mucosal protective applications; take with or after food.,No,Gut mucosal repair,No,Yes,No,No,No,Yes,Low,Perimenopause-specific GI health RCTs are absent; most evidence from gastroenterology settings.
Bromelain,Pineapple enzyme; as Bromelain; pineapple protease,Other,Some,RCTs show anti-inflammatory and sinusitis benefits. Some evidence for muscle recovery after exercise. Antiplatelet activity. Often combined with quercetin and other anti-inflammatories.,200,1000,mg,Anticoagulant/antiplatelet — caution with blood thinners; may affect some drug absorption; take on empty stomach for systemic anti-inflammatory effect; with food for digestive enzyme effect.,No,Anti-inflammatory,No,No,Yes,No,No,Yes,Low,Perimenopause-specific anti-inflammatory RCTs are absent.
Black Pepper Extract,Bioperine; Piperine; as Black Pepper Extract; as Piperine,Other,Some,"RCTs show piperine significantly enhances bioavailability of curcumin (2000%), selenium, CoQ10, and other supplements by inhibiting intestinal metabolism. Standalone benefits limited at supplement doses.",5,20,mg,"CYP3A4 inhibitor — may interact with many medications similarly to grapefruit; at supplement doses (5-20mg), interactions are generally clinically minor but caution with narrow therapeutic index drugs; Bioperine is standardised form.",No,Bioavailability enhancer,Possible,No,No,No,No,Yes,Low,CYP3A4 inhibition magnitude at supplement doses (5-20mg) in perimenopause populations and interaction with multiple simultaneous medications not established.
Copper Bisglycinate,as Copper Bisglycinate; chelated copper; copper glycinate,Mineral,Limited,"Limited standalone RCT evidence; copper is an essential cofactor for iron metabolism, collagen crosslinking, and superoxide dismutase antioxidant activity. Bisglycinate form offers superior bioavailability versus gluconate or sulfate forms.",0.9,3,mg,Commonly included to offset copper depletion from zinc supplementation; bisglycinate form preferred for tolerability; upper tolerable limit 5mg/day.,No,Metabolic cofactor,No,No,No,No,No,Yes,Low,Independent perimenopause-specific RCTs are absent.
Potassium Citrate,as Potassium Citrate; potassium; dipotassium citrate,Mineral,Some,RCTs support potassium for blood pressure management and kidney stone prevention. Electrolyte balance relevant to perimenopausal cardiovascular health. Most dietary potassium should come from food.,99,800,mg,EU supplements limited to 99mg per daily dose in many jurisdictions due to cardiovascular risk at high supplemental doses; blood pressure medication interaction; caution in renal impairment; high-dose supplementation requires medical oversight.,No,Blood pressure,No,No,No,No,No,Yes,Medium,Perimenopause-specific cardiovascular supplementation RCTs using potassium are limited.
Sodium (as Sodium Chloride),Salt; NaCl; as Sodium; sodium chloride,Excipient,None,Electrolyte; not supplemented in women's health supplements for nutritional benefit — relevant only as excipient or in electrolyte formulas. Excess sodium associated with hypertension and calcium excretion.,0,0,mg,Most women consume excess sodium from diet; supplemental sodium only appropriate in electrolyte/sports contexts; sodium ascorbate is common vitamin C form that contributes sodium.,No,None,No,No,No,No,No,Yes,Low,Not applicable in typical women's health supplementation context.
Phosphorus,Phosphate; dicalcium phosphate; as Phosphorus; DCP,Mineral,None,Essential mineral but widespread in diet; supplementation not appropriate in otherwise healthy perimenopausal women. Used as excipient (DCP) in tablets. Excess phosphorus impairs calcium and magnesium absorption.,0,0,mg,Dicalcium phosphate commonly used as excipient/filler in tablets; adequate phosphorus is easily obtained from diet; supplementation not recommended in typical healthy perimenopausal women.,No,None,No,No,No,No,No,Yes,Low,Not applicable for supplementation in healthy perimenopausal women.
Larch Arabinogalactan,ResistAid; as Larch Arabinogalactan; arabinogalactan; AG,Other,Limited,Limited RCT evidence for immune modulation and prebiotic activity. Soluble fibre with bifidogenic properties. Some evidence for NK cell activity. Relatively few high-quality trials.,4500,9000,mg,Generally well tolerated; mild gas and bloating possible; soluble fibre prebiotic activity; limited independent clinical evidence base.,No,Immune/prebiotic,No,No,No,No,No,Yes,Low,Perimenopause-specific RCTs are absent; limited evidence base compared to established prebiotics.
Saccharomyces cerevisiae,Brewers yeast; Nutritional yeast; as Saccharomyces cerevisiae; selenium yeast; chromium yeast,Other,Some,Used as substrate for selenium and chromium yeast; whole yeast has B vitamin mineral and beta-glucan content. Beta-glucan from yeast has immune modulation evidence. Not the same as S. boulardii probiotic.,500,2000,mg,Different from Saccharomyces boulardii probiotic strain; good source of B vitamins and minerals; yeast beta-glucan has different immune evidence from oat/barley beta-glucan; avoid in yeast allergy.,No,Nutritional support,No,No,No,No,No,Yes,Low,Perimenopause-specific clinical outcomes using S. cerevisiae supplementation are not well established.
Grape Skin Extract,Anthocyanins; Pterostilbene; as Grape Skin Extract; red grape polyphenols; OPC,Botanical,Limited,"Limited RCT evidence for cardiovascular and cognitive benefits. Contains anthocyanins, pterostilbene, and OPCs. Pterostilbene may be more bioavailable than resveratrol. Limited perimenopause-specific data.",100,500,mg,Pterostilbene (methylated resveratrol analogue) has better bioavailability than resveratrol; anthocyanin content varies widely between products; mild anticoagulant activity.,No,Antioxidant/cardiovascular,No,No,Possible,No,No,Yes,Low,Perimenopause-specific RCTs for cognitive and cardiovascular outcomes are absent; standardisation varies.
Açaí Berry,Euterpe oleracea; as Açaí; Acai berry extract; Açaí palm,Botanical,None,No meaningful human RCT evidence for any specific health outcome. Marketed heavily for antioxidant and weight loss claims. Antioxidant capacity in vitro does not translate to clinical outcomes.,1000,4000,mg,Antioxidant capacity tests (ORAC) do not predict clinical benefit; weight loss claims unsupported by RCT evidence; no safety concerns at supplement doses but no demonstrated efficacy.,No,None,No,No,No,No,No,Yes,Low,No clinical RCT evidence base exists to support marketed health claims.
Pomegranate Extract,Punica granatum; as Pomegranate Extract; pomegranate polyphenols; Pomanox; ellagic acid,Botanical,Some,"Some RCTs show cardiovascular, blood pressure, and joint health benefits. Ellagitannins converted to urolithins by gut bacteria — variable individual response. Some menopausal symptom data.",250,1000,mg,Urolithin conversion from ellagitannins is gut microbiome dependent — variable individual response; Pomanox and PomellaTM are standardised extracts with human data; generally well tolerated; mild anticoagulant effect.,Yes,Cardiovascular/joint,No,No,Possible,No,No,Yes,Low,Individual response variation based on urolithin-producing microbiome status makes population-level efficacy prediction difficult.
Urolithin A,Mitopure; as Urolithin A; UA; ellagitannin metabolite,Performance,Some,"Post-2022: Mitopure (Timeline Nutrition) has RCT evidence for mitophagy activation, muscle endurance, and cellular energy in middle-aged and older adults. Novel ingredient with growing evidence base specific to ageing populations.",250,1000,mg,Post-2022: Mitopure has now accumulated multiple human RCTs; urolithin A bypasses gut microbiome conversion step unlike pomegranate extract; generally well tolerated; novel ingredient with good safety profile to date; highly relevant to perimenopausal cellular health.,Yes,Cellular energy/muscle,No,No,No,No,No,Yes,Low,Post-2022: evidence base growing rapidly; long-term safety data (>12 months) and perimenopause-specific hormonal outcome data needed.
